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Coronary atherosclerosis and the vulnerable plaque 
Of the 57 million global deaths in 2008, 17.3 million (30%) were due to 
cardiovascular disease, of which heart attacks were responsible for 7.3 million deaths1. 
This high mortality poses a great burden to society, both in terms of mortality and 
morbidity. The rupture of vulnerable atherosclerotic plaques is a major contributor to 
acute cardiovascular events and sudden cardiac deaths2. The vulnerability of an 
atherosclerotic plaque – its susceptibility to rupture – is known to be related to the 
composition of the plaque, the distribution of mechanical stress within it, and the 
presence and extent of associated inflammation3-5. One of the most common types of 
vulnerable plaques is the thin-cap fibroatheroma (TCFA). These lesions are 
characterized by a thin fibrous cap, weakened by the presence of macrophages, covering 
a lipid-rich necrotic core3. These and other known markers of plaque vulnerability are 
depicted in the schematic in Figure 1a. Figure 1b shows the gross morphology of a 
ruptured TCFA. 
 
Figure 1. The vulnerable plaque. a) Typical morphological traits associated with plaque 
vulnerability. b) Gross morphology of human coronary artery. Ruptured vulnerable plaque, 
showing disruption of fibrous cap at the shoulder region of the plaque (red arrowhead) and 
thrombus (Thr) superimposed. NC = necrotic core6. 
Most of our knowledge about vulnerable coronary plaques originates from 
histological studies of ex vivo material, which consist of sectioning and staining of cells 
and tissues, after which they are examined under a light microscope. Histology is often 
used as the gold standard to evaluate the performance of new imaging modalities, 
particularly for those techniques that aim to image tissue composition. The histology 
sections of a coronary TCFA, shown in Figure 2, reveal several important hallmarks of the 
vulnerable plaque. The low power (20x) view of the Movat pentachrome overview stain 
(Figure 2a) shows an eccentric plaque with a relatively large necrotic core covered by a 
thin cap.  
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Figure 2. Thin-cap fibroatheroma (TCFA). a) Coronary artery cross-section with an eccentric 
plaque showing a thin fibrous cap overlying a relatively large necrotic core; greyish material in 
lumen is barium gelatin (Movat Pentachrome). b) Magnification (5x) of the boxed area in a shows 
an advanced necrotic containing numerous cholesterol clefts and cellular debris covered by a thin, 
cellular-rich fibrous cap. c) Immunohistochemical staining reveals numerous CD68-positive 
macrophages (MΦ) within the fibrous cap (rose-red reaction product). d) Few alpha-actin 
positive smooth muscle cells (SMCs) are found within the fibrous cap. Adapted from7. 
Rupture of the thin fibrous cap due to high mechanical stress will release the lipid-
rich thrombogenic contents of the necrotic core into the bloodstream. The subsequent 
formation of a platelet-rich thrombus may result in occlusion, either at the location of the 
rupture or downstream from the lesion site. If this occlusion takes place in one of the 
coronary arteries, the vessels that deliver oxygen-rich blood to the myocardium, the 
result may be unstable angina or a myocardial infarction. The location, size and anatomy 
of the coronary arteries pose specific challenges for imaging and treatment. They are 
small, lie relatively deep in the body and curl around the heart, which limits their 
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accessibility. The motion of the beating heart presents an additional difficulty. The main 
branches of the coronary arteries are shown in Figure 3.  
 
 
 
Figure 3. Anatomy of the main coronary arteries. The left and right coronary arteries both 
originate from the root of the aorta. The left coronary artery (LCA) branches off into the left 
circumflex coronary artery (LCX) that supplies oxygen and nutrients to the left ventricle, and the 
left ascending coronary artery (LAD) that supplies two thirds of the anterior heart surface. The 
right coronary artery (RCA) supplies the right ventricle muscle8. 
Treatment of symptomatic myocardial disease 
A person experiencing myocardial ischemia or a myocardial infarction is often treated 
with a percutaneous coronary intervention (PCI, see Figure 4). During this non-surgical 
procedure, an intervention cardiologist feeds a catheter from the femoral or radial artery 
up through the aorta up to the site of occlusion in the coronary artery. At the occlusion 
site, the artery is opened up by balloon inflation. A stent is placed to permanently keep 
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the artery open. Recently, bioabsorbable drug-eluting coronary stents (scaffolds) were 
developed to prevent restenosis through late stent thrombosis9. 
 
 
Figure 4. Percutaneous coronary intervention (PCI). A catheter is fed from the femoral (depicted 
here) or radial artery through the aorta into the coronary artery up to the site of the occlusion 
(blood clot). After opening the artery through balloon angioplasty, a stent is placed 
(http://jama.jamanetwork.com/article.aspx?articleid=198185). 
Visualization of coronary atherosclerosis 
To guide the catheter threading during PCI, coronary angiography is used: after 
injection of a radio-opaque contrast agent via the guiding catheter, real-time X-ray 
images of the coronary arteries are made. Angiography provides 2D projections of the 
lumen geometry (angiograms) with a spatial resolution of 200 µm10 of the arteries that 
are used to determine the degree of stenosis. Since atherosclerotic plaques are often 
characterized by outward remodeling, an angiogram can sometimes show an adequate 
or even normal luminal cross-section in the presence of advanced atherosclerosis, as is 
illustrated in Figure 5. 
Non-invasive imaging techniques 
Computed tomography (CT) coronary angiography has seen rapid advances over the 
last few years. Multidetector CT (MDCT) using a 64-slice scanner has an improved 
spatial resolution of 0.4 mm and a faster rotation time (330 ms) compared to prior 
CHAPTER 1 
12 
MSDT scanners. The most important distinguishing feature of MDCT for coronary 
imaging is its high negative predictive value, making it a useful tool for screening in an 
emergency room setting11. MDCT shows good correlation with intravascular ultrasound 
(IVUS, see below) for measuring plaque burden, plaque volume, and remodeling index12, 
where accuracy of this measurement benefits strongly from the improved resolution 
offered by 64-slice scanners. Vulnerable plaque features have been identified using 
MDCT, but only in retrospective or observational studies13-15. Necrotic core plaques are 
detected using an attenuation threshold of 30 Hounsfield units (HU), which is subject to 
blooming and resolution artifacts and large overlap in HU is found between tissue types. 
This is a problem particularly in the presence of spotty calcification, which is recognized 
as one of the hallmarks of a vulnerable plaque. Vulnerable plaque criteria from a 
prospective trial are lacking, and generalization from studies cited above is complicated 
due to the limited resolution and variability in the results. The use of MDCT as a 
screening tool for vulnerable plaque detection is hampered by the absence of such 
criteria, as well as the use of ionizing radiation. For these reasons, clinical use of coronary 
MDCT remains mainly angiographic16. 
Coronary magnetic resonance (MR) imaging has greater potential for tissue 
specificity than MDCT imaging, due to the use of multicontrast MR, generated by T1- 
and T2-weighted, proton–density–weighted, and time–of–flight imaging17. These imaging 
sequences allow for differentiation of plaque components on the basis of biophysical and 
biochemical parameters such as chemical composition and concentration, water 
content, physical state, molecular motion, or diffusion. MR provides imaging without 
ionizing radiation and can therefore be repeated over time and thus used to serially 
monitor patients with high-risk plaques. It suffers from the same limitations as MDCT 
though, but to a larger degree: current coronary MR sequences have resolutions in the 
order of 1 mm18 and temporal resolutions of 100 ms acquisition time per heartbeat, at 
best19. Especially in the case of coronary MR, the low temporal resolution hinders 
quantitative analysis. Additionally, the long acquisition time render it more susceptible to 
cardiac and respiratory motion artifacts. These technological limits have precluded 
coronary plaque imaging studies of a significant size.  
Intravascular imaging techniques 
The current standard for intravascular assessment of coronary atherosclerotic 
disease and guidance of interventional procedures is intravascular ultrasound (IVUS). 
This modality produces images based on the reflected amplitude of ultrasound pulses, 
providing information on both lumen geometry and the structure of the vascular wall 
with a resolution of approximately 100 µm and an imaging depth of 7 mm. The typical 
IVUS longitudinal pullback scanning rate is 0.5 mm/s. IVUS is used in clinical practice 
and trials to measure lumen dimensions, degree of stenosis, plaque burden, and to 
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assess calcification and stent deployment. The sensitivity and specificity of IVUS 
grayscale for plaque composition is limited20 because the contrast between soft tissue 
types is minimal. Examples of IVUS cross-sectional images of a healthy and diseased 
section a human LAD are shown in Figures 5b and 5c, respectively 
 
Figure 5. Example of a false-negative angiogram due to outward remodeling. a) Angiogram of left 
anterior descending artery (LAD) is completely normal. The 2 sites indicated by the arrows have 
comparable lumen size but while the IVUS image of the more distal site b) shows little disease, 
the IVUS image of the more proximal site c) reveals a large eccentric lesion.21 
IVUS radiofrequency data analysis techniques for tissue characterization have been 
developed as an extension to grayscale imaging22. Today, two commercial IVUS systems 
offer coronary tissue characterization: VH-IVUS (20 MHz, phased-array transducer, 
Volcano Therapeutics), and iMap™ (40 MHz, mechanical-type transducer, Boston 
Scientific). VH-IVUS differentiates four tissue types: necrotic core, fibrous, fibrofatty, and 
dense calcium23 but has shown limited accuracy in complex lesions in a porcine 
model24,25. iMap distinguishes similar tissue types: fibrotic, lipidic, necrotic, and calcified 
tissue. An in vivo comparison between VH-IVUS and iMap yielded a significant and 
systematic variability in plaque composition estimates, as illustrated by Figure 626. 
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Therefore, further exploration of these tissue characterization techniques in a large 
population is warranted to establish clinical utility. 
 
Figure 6. Corresponding iMap (top) and VH-IVUS (bottom) cross-sections of atherosclerotic 
human coronary artery. a) iMap IVUS only and b) iMap tissue characterization images. c) VH-
IVUS IVUS only image and d) VH-IVUS tissue characterization images. iMap interprets the 
wire artifact and calcium shadow as necrotic tissue, while VH-IVUS reports the same area as 
fibrous or fibrofatty tissue26. 
Intravascular optical coherence tomography (IVOCT) is another modality based on 
the echo delay of light backscattered from the tissue. IVOCT provides high resolution 
images (15 µm) but with limited depth penetration (1–2 mm)27. Flushing of the artery 
under inspection is required due to the strong signal attenuation through blood. 
Widespread clinical acceptance was achieved after the introduction of high frame rate 
(> 100 frames per second; fps) and pullback speed (20-40mm/s). Compared to IVUS, 
OCT offers better assessment of lumen geometry, fibrous cap thickness, stent structure, 
stent strut coverage and detection of macrophages28,29. On the other hand, tissue 
characterization by IVOCT is less straightforward and is currently a topic of intense 
research30. Figure 7 depicts an OCT cross-sectional image of a human coronary artery 
presenting a TCFA. 
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In the past decade, a number of other optical technologies have aimed to improve 
intravascular tissue characterization. The most advanced in terms of clinical penetration 
is near-infrared reflection spectroscopy (NIRS), which is developed and commercialized 
by Infraredx. It collects a reflection spectrum of the arterial wall, through blood, and 
identifies the presence of lipid-core plaque in the artery wall. Recently, our laboratory 
collaborated with Infraredx Inc. to develop a hybrid NIRS/IVUS catheter that combines 
morphological imaging and lipid detection31-33. This is the first multimodality device to 
enter the clinical arena. Combined interpretation of IVUS and NIRS data may yield an 
assessment of the lesion morphology, as is illustrated by Figure 8. This also highlights a 
limitation of NIRS: it is not an imaging modality. Because it lacks depth resolution, NIRS 
can identify the presence but not the amount or the location, relative to the lumen, of the 
lipid core. The sensing depth of NIRS is not well quantified. 
What is needed? 
Since composition is a major determinant of the vulnerability of an atherosclerotic 
plaque, there is a need for an imaging technique that provides adequate pathological and 
plaque composition information, preferably in combination with a morphology showing 
modality. Imaging modalities such as IVUS and OCT provide morphological images with 
limited plaque composition information. Chemical diagnostic methods such as Raman 
spectroscopy and near-infrared absorption spectroscopy, on the other hand, supply 
tissue characterization but provide no depth resolution. A rapid and non-destructive 
technique to assess the lipid content of atherosclerotic plaques could have a direct 
Figure 7. OCT image of an eccentric 
plaque with an intimal rupture. The 
signal-poor area from 12 to 7 o'clock 
indicates presence of a necrotic core, 
overlaid by a signal-rich fibrous cap. 
The layered structure from 8 to 12 
o'clock shows a mildly thickened fibrous 
intima covering the darker media. 
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impact on patient management, improve our understanding of the progression or 
regression of the disease and can be used to investigate drug efficacy. 
 
Figure 8. NIRS-IVUS images of a human LAD. a) The angiogram demonstrates a mild stenosis 
in the proximal LAD (blue arrow), and a more severe stenosis in the mid-LAD (green arrow).  
b) The NIRS-IVUS chemogram (top) and block chemogram (bottom) show that both lesions 
contain large lipid core plaques (LCP). Cross-sectional IVUS views c,d,e), with the chemogram 
data overlaid in a halo around the IVUS image and the block chemogram color value portrayed in 
the central catheter area. IVUS reveals the proximal LAD lesion d) is an ulcerated LCP and the 
mid-LAD lesion e) is a bulky LCP with tight stenosis34. 
 
To fulfill this need, we are developing a novel intravascular technique, called 
intravascular photoacoustic (IVPA) imaging. IVPA is the most recent addition to 
spectroscopic diagnostic techniques. It has demonstrated the ability to directly image 
tissue components in the vessel wall, with high chemical specificity for lipid type. There 
is potential to extend the technology to identify other factors, such as dense macrophage 
infiltration, associated with plaque vulnerability. The same catheter can be used 
simultaneously to image the arterial wall architecture by IVUS.  
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Thesis outline 
Chapter 2 introduces IVPA imaging. The photoacoustic principle is explained and an 
overview of the developments in the field of IVPA to date is given. Lipids and calcification 
have been the primary targets of IVPA imaging, using endogenous contrast provided by 
the tissue absorption spectra but considerable work has also been done on visualizing 
macrophages and matrix metalloproteinase using exogenous absorbers. Additionally, the 
trade-offs and choices in the design of dedicated IVPA catheters are discussed. 
Chapter 3 describes the design and performance of two prototype integrated 
IVPA/IVUS catheters that were developed and built in-house. The performance of the 
catheters was tested on several phantoms using an experimental setup.  
Chapter 4 demonstrates co-registered IVPA/IVUS imaging of human coronary 
atherosclerotic plaque. Data was obtained from two fresh coronary arteries ex vivo, 
showing different stages of disease. Spectroscopic IVPA at different wavelengths 
between 1180 and 1230 nm was performed to visualize the lipid content of an 
atherosclerotic lesion. 
Chapter 5 presents more chemically detailed imaging of the lipid content of human 
coronary atherosclerotic arteries. The natural history of atherosclerosis is marked by 
changes in the lipid biochemistry in the diseased arterial wall. As lesions become more 
vulnerable, different cholesterol species accumulate in the plaque. We demonstrate 
spectroscopic IVPA imaging of the most important lipid components of human 
atherosclerotic plaques and visualize connective tissue layers of the adventitia and the 
fatty acid containing adipose cells in the peri-adventitial tissue. 
Chapter 6 reports the development of several methods for the automatic detection 
and the differentiation of lipids in atherosclerosis development. Such methods make 
atherosclerotic lipid content information readily available to the clinician, without the 
need for observer-dependent and time-consuming image interpretation.  
Chapter 7 compares the performance of spectroscopic IVPA imaging of human 
coronary in two spectral bands that signal the presence of lipids: 1.2 µm and 1.7 µm. 
Tradeoffs in terms of sensitivity, imaging depth, and possibly chemical specificity exist 
between the two spectral bands are discussed. We measured a lipid containing vessel 
phantom and an atherosclerotic human coronary artery ex vivo in both spectral bands to 
provide a direct comparison between the two wavelength ranges.  
Chapter 8 summarizes the accomplishments and conclusions of the work presented 
in this thesis, and discusses future directions for the field of IVPA. 
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Based on book chapter by Krista Jansen, Gijs van Soest, and Antonius F.W. van der 
Steen, Photoacoustic Imaging of Coronary Arteries: current status and potential clinical 
application, in: C. Arampatzis, E.P. McFadden, L.K. Michalis, R. Virmani, P.W. Serruys 
(Eds.) Coronary atherosclerosis: current management and treatment, Informa 
Healthcare, London, UK, 2012, pp. 166-174. 
 
and the manuscript by Krista Jansen, Gijs van Soest, and Antonius F.W. van der Steen, 
Intravascular photoacoustic imaging: a new tool for vulnerable plaque identification. 
submitted  
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Abstract 
The vulnerable atherosclerotic plaque is believed to be at the root of the majority of 
acute coronary events. Even though the exact origins of plaque vulnerability remain 
elusive, the thin cap fibroatheroma, characterized by a lipid-rich necrotic core covered by 
a thin fibrous cap, is considered to be the most prominent type of vulnerable plaque. No 
clinically available imaging technique can characterize atherosclerotic lesions to the 
extent needed to determine plaque vulnerability prognostically. Intravascular 
photoacoustic imaging (IVPA) has the potential to take a significant step in that 
direction by imaging both plaque structure and composition. IVPA is a natural extension 
of intravascular ultrasound (IVUS) that adds tissue type specificity to the images. IVPA 
utilizes the optical contrast provided by the differences in the absorption spectra of 
plaque components to image composition. Its capability to image lipids in human 
coronary atherosclerosis has been demonstrated extensively ex vivo and has recently 
been translated to an in vivo animal model. Other disease markers that have been 
successfully targeted are calcium and inflammatory markers, such as macrophages and 
matrix metalloproteinase (MMP); the latter two through application of exogenous 
contrast agents. By simultaneously displaying plaque morphology and composition, IVPA 
can provide a powerful prognostic marker for disease progression, and as such has the 
potential to transform the current practice in percutaneous coronary intervention. 
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Principle of photoacoustics 
In photoacoustic imaging, the tissue is irradiated by short laser pulses with a length of 
several nanoseconds. Absorption of laser light transfers the optical energy to the tissue, 
which causes a transient pressure rise35. This initial pressure rise acts as an acoustic 
source which generates a broadband wave propagating through the tissue. The acoustic 
wave can be detected with an ultrasound transducer. In IVPA, the same ultrasound 
transducer that is used in IVUS can be employed. The principle of IVPA is shown in 
Figure 1. 
 
 
Figure 1. Sketch of the IVPA principle. A laser pulse (green) is sent from the catheter C to the 
vessel wall containing a plaque (yellow). The light excites an acoustic wave (blue curves) through 
optical absorption and the associated thermoelastic expansion (red star). The graph on the right 
shows a time trace of the acoustic signal after the laser fires at time t = 0. 
The signal strength in photoacoustics is proportional to the local absorption 
coefficient of the tissue, the light intensity, and the Grüneisen parameter, describing the 
thermo-acoustic conversion efficiency. The variation of the absorption coefficient with 
the excitation wavelength is the tissue-specific chemical absorption spectrum, which 
permits differentiation of tissue type (Figure 2). The photoacoustic excitation 
wavelengths can be selected to give maximum absorption contrast between the relevant 
components in the vessel wall and plaque, such as collagen, calcified tissue, and 
lipids36,37, to image plaque composition using endogenous contrast. Alternatively, 
exogenous absorbers can be utilized to generate contrast for vulnerable plaque markers 
that would otherwise remain invisible due to their relatively featureless or low-amplitude 
absorption spectra. Macrophages are an example of such plaque components. 
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Figure 2. Absorption spectra of various absorbers present in coronary artery vessel wall. Water, 
fat, and connective tissue (collagen and elastin) are the major contributors to the absorption 
spectra of human tissues in the NIR spectral region38.  
Development of IVPA 
Endogenous contrast: imaging of lipids and calcification 
The goal of IVPA imaging is the chemical characterization of vessel wall components. 
Historically, development has been driven by the availability of suitable light sources. For 
this reason the first spectroscopic measurements focused on the visible wavelength 
range (410–680 nm)39,40. Through PA imaging of human atherosclerotic aorta 
specimens, contrast for lipids was found at 461 and 532 nm41, and contrast for calcium at 
308 nm42. Discrimination between normal and atheromatous areas of arterial tissue in 
the visible range has an important drawback: at these wavelengths blood (hemoglobin) 
absorption is also very high. Introduction of infrared sources prompted investigation of a 
wider range of excitation wavelengths (680–1800 nm). Blood absorption is especially 
low in the wavelength range from 680 to 1300 nm. In this wavelength range, the 
absorption spectrum of lipids exhibits a large peak around 1210 nm, see Figure 2.  
The group led by Emelianov pioneered spectroscopic IVPA to distinguish between lipid-
rich tissue and collagen43. They performed imaging of ex vivo normal and atherosclerotic 
rabbit aorta samples using a bench-top setup with a commercial IVUS catheter and 
external illumination. They found different spectral slopes in the IVPA image in regions 
identified as lipid-rich, collagen type I, and collagen type III. The same group 
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subsequently exploited the absorption peak around 1210 nm to image lipids in 
atherosclerotic rabbit aorta44.  
Allen and Beard were the first to exploit the low blood absorption in the near infrared 
to discriminate between lipid-rich and normal vascular tissue while imaging through 
blood45,46 (up to a depth of 2.8 mm). Imaging through blood is difficult because of the 
strong attenuation of the excitation light. They investigated samples of atherosclerotic 
human aorta and confirmed the presence of lipids by comparing the photoacoustic 
spectra obtained in a region within the plaque to the spectral signature of a lump of fat.  
Investigation of photoacoustic response at longer wavelengths yielded an additional 
lipid specific absorption feature around 1720 nm45. Bo Wang et al.47 imaged an 
atherosclerotic rabbit aorta ex vivo in the presence of luminal blood using excitation light 
at that wavelength. They demonstrated single wavelength IVPA imaging of lipids 
through blood using relatively low laser output energy. However, the specificity of this 
single wavelength method for lipids in human atherosclerotic plaques remains to be 
investigated.  
The first demonstration of in vivo IVPA was performed using the same 1720 nm 
single wavelength in a hypercholesterolemic rabbit model48, see Figure 3. The study was 
limited by the slow laser system, which necessitated a complex breath gating acquisition. 
It did show, however, that in vivo imaging without flushing the blood from the artery is 
possible.  
 
Figure 3. In vivo IVPA/IVUS imaging of lipid in an abdominal rabbit aorta. IVPA image a) and 
combined IVPA/IVUS image b). The location of lipid deposits in the vessel wall is visualized in 
the combined IVPA/IVUS image. Adapted from Wang et al.48 
In most IVPA experiments, lipid rich atherosclerotic plaques were distinguished from 
normal arterial tissue by simply comparing the tissue spectral signature to the 
absorption spectra of lipids. A more sophisticated spectroscopy inversion approach 
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could provide robust identification of a wider range of tissue types, including collagen, 
elastin and calcifications. Pu Wang et al.49 recorded spectroscopic PA data of a phantom 
consisting of rat-tail tendon and fat between 1650 and 1850 nm. A multivariate curve fit 
analysis yielded the spatial distribution of collagen and lipids in the phantom.  
Recently, single wavelength IVPA imaging at 1720 nm was also demonstrated on 
human coronary atherosclerosis ex vivo48. 
Exogenous contrast: imaging of macrophages and matrix 
metalloproteinase (MMP) 
Vulnerable plaque markers that lack sufficient endogenous contrast can be imaged 
using exogenous absorbers. Macrophages are an example of such plaque components. 
They do not provide endogenous contrast but can be visualized using gold nanoparticles.  
 
 
Figure 4. Combined IVPA/IVUS images and IVUS image of a diseased rabbit aorta injected with 
macrophages loaded with gold nanoparticles (blue arrows). The combined IVPA/IVUS images 
taken at 700 nm wavelength a) showed high photoacoustic signal at the injected regions denoted 
by arrows. Adapted from Wang et al.50 
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The gold nanoparticles have a distinct absorption peak in the visible wavelength 
 range. When the nanoparticles are endocytosed by macrophages, they aggregate. These 
aggregated gold nanoparticles have a shifted peak in the absorption spectrum compared 
to the (extracellular) non-aggregated gold nanoparticles, providing image contrast. This 
principle was proven in an atherosclerotic rabbit aorta injected with macrophages loaded 
with gold nanoparticles in a bench-top experimental setting50. The resulting IVPA 
images, shown in Figure 4, demonstrate that the aggregated gold nanoparticles produce 
the strongest photoacoustic signal at 700 nm wavelength. The extravasation of 
nanoparticles in atherosclerotic regions with compromised luminal endothelium and 
acute inflammation, was demonstrated by systemic injection of gold nanoparticles in a 
live rabbit model, followed by ex vivo IVPA imaging51. IVPA/IVUS imaging at 750 nm 
revealed a high photoacoustic signal from localized gold nanoparticles in regions with 
atherosclerotic plaques. 
Matrix metalloproteinase (MMP) activity, an indicator of plaque instability, can be 
detected using a MMP-activatable fluorescent imaging agent. MMPSense (MMPSense™ 
680; VisEn Medical) is such an imaging agent and is activated by different enzymes, 
most prominently MMP2/9 and trypsin, and to a lesser extent by other proteases. Once 
activated, it becomes optically absorbing. More than 80% of the absorbed energy is 
transferred into photoacoustic signals, due to the low quantum yield of the dye. It has a 
much lower absorption than gold nanoparticles, however, and thus produces a much 
lower PA signal intensity.  
MMPSense was used for detecting MMP activity in human carotid arteries52. 
Immediately after endarterectomy, the atherosclerotic specimens were incubated in 
MMPSense. The morphological photoacoustic images, shown in Figures 5a,c,e, were 
obtained using a small-animal imaging system. The activated probe was distinguished 
from the background and the inactive probe, by acquiring photoacoustic data at several 
wavelengths and analyzing spectral contributions on a per-pixel basis. The results 
matched well with fluorescence microscopy (Figures 5b,d,f). 
 
Photoacoustic generation is temperature dependent, and the dependence is tissue 
specific, which provides another contrast mechanism. With increasing tissue 
temperature, the PA amplitude of atherosclerotic plaque lipids decreased while the PA 
amplitude of peri-adventitial lipids and abdominal fat remained relatively constant 
between 20–38°C53. Thermal IVPA imaging of atherosclerotic lipids has the advantage 
over spectroscopic IVPA that only one wavelength is needed. However, creating reliable 
temperature differences in vivo might prove difficult. 
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Figure 5. Localization of MMP activity in three carotid specimen. Samples 1 (top row) and 2 
(middle row) were incubated in MMPSense 680 while sample 3 (bottom row) was incubated in 
PBS. a), c) and e) PA imaging results of intact plaques. Cross-sectional spectroscopic 
reconstruction, revealing location of MMPSense 680 activity in the slice, is shown in green color 
that is superimposed onto morphological photoacoustic images. b), d) and f) The corresponding 
epi-fluorescent images from dissected plaque (in green) superimposed onto color images of 
cryosections from the three carotid plaque specimen. Adapted from Razansky et al.52 
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IVPA catheter development 
Practical in vivo implementation of IVPA requires the development of a dedicated 
catheter device. Such a device needs to incorporate an optical axis to deliver the light to 
the vessel wall and an ultrasound detector to detect the photoacoustic signals. Various 
designs have been proposed.  
A miniature, all-optical IVPA probe based on a Fabry-Perot ultrasound sensor was 
built53,54. It had a diameter of only 250 µm and exhibited good acoustic sensitivity. This 
all-optical design of an IVPA imaging probe lacks IVUS functionality but has the potential 
for multi-modal operation, and could be combined with OCT and other optical imaging 
and sensing methods. 
Devices that contain an ultrasound transducer for detection of photoacoustic signals, 
can be used for combined IVPA/IVUS imaging to provide simultaneous information on 
composition and morphology of the arterial wall. Two early prototype catheters 
combined an optical fiber for light delivery with a commercially available IVUS imaging 
catheter (AtlantisTM SR plus, Boston Scientific, Inc.) for both pulse-echo ultrasound 
imaging and detection of photoacoustic signals55. Light was directed toward the vessel 
wall using an angle-polished fiber (“side-fire fiber”) or a silver coated glass mirror. 
A step towards an array catheter for photoacoustic imaging analogous to Volcano’s 
electronic IVUS catheter was made56. When using omni-directional optical excitation 
and ultrasound transmission and detection, no rotation is needed and the required laser 
pulse repetition rate is reduced. A prototype of a catheter with omni-directional light 
delivery consisted of a multimode optical fiber coupled to a cone-shaped mirror for 
illumination and an optical ultrasound detector. The outer diameter of the device was  
3 mm. 
 
Figure 6. Schematic of the integrated IVUS/IVPA probe: top view a) and front view b); the light 
beam is in green and the acoustic beam in gray. Adapted from Li et al.57 
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Since the diameters of the catheters used in the above-mentioned studies were too 
large to allow use in human coronary arteries, they have only been tested on phantoms, 
rabbit aortas, and on human arteries that were opened up to enable en-face scanning of 
the luminal surface. Recently, a hybrid IVPA/IVUS catheter with an outer diameter of  
1.2 mm was built, see Figure 6. It consisted of a side-firing optical probe and a side-
viewing ultrasonic transducer arranged side-by-side57. The optical probe comprised a 
fiber tip connected to a 45-deg polished microprism that was sealed inside a glass 
capillary tube to preserve an air-glass interface deflecting the beam by total reflection. 
The fiber ensemble and transducer were packaged in polyimide tubing. The side-by-side 
arrangement of the fiber and transducer minimizes the offset of the beams which 
provides good optical–acoustic overlapping, especially close to the probe.  
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Abstract 
We developed two prototype intravascular photoacoustics (IVPA) and ultrasound 
(IVUS) catheters, based on different geometries, to image atherosclerotic plaque 
structure and composition, important determinants of plaque vulnerability. The first 
prototype consists of an optical fiber that is mounted in the central hole of a ring shaped 
ultrasound transducer and a silver mirror that deflects both the light and ultrasound 
beam sideways (30 MHz coaxial probe). The second prototype comprises an angle-
polished optical fiber and a cylindrical transducer (30 MHz dual beam probe). In both 
cases, a 30 MHz single-element transducer was used. We quantified the imaging 
performance of the catheters on isolated point targets. Based on the results, we elected 
the dual beam design for further miniaturization and built a catheter comprising the 
same angle-polished optical fiber and a 44.5 MHz single crystal transducer. This 
prototype had an outer diameter of 1 mm only. We tested its imaging performance on 
isolated point targets and a vessel mimicking phantom.  
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Introduction 
Intravascular photoacoustic (IVPA) imaging has the potential to image 
atherosclerotic plaques in unprecedented chemical detail. It uses a combination of light 
and ultrasound to image the vessel wall anatomy (using pulse-echo intravascular 
ultrasound [IVUS] imaging) and photoacoustic imaging, employing the chemical 
specificity of the optical absorption spectrum to identify tissue type. It requires a 
catheter that can perform IVUS, and has an optical port to illuminate the artery wall. 
IVUS imaging requires a high-frequency (> 30 MHz center frequency) transducer.  
In order to access a coronary vessel, the outer diameter of the probe must eventually be 
less than 1 mm. 
Optical access is realized by the use of an optical fiber which runs along the length of 
the catheter. The illuminated area must lie within the field of view of the ultrasound 
element. We explore two geometries here to assess their performance for IVPA. 
An elegant solution to fulfill the geometrical requirements is the use of coaxial 
beams. In this realization, the optical fiber illuminates the tissue through a central hole in 
the transducer, and a mirror directs both beams towards the vessel wall. Advantages of 
this design are exact optical/ultrasound coregistration and longer acoustic path lengths, 
allowing to remove transmit artifacts. A downside is the loss of transducer area and the 
need for fluid filling the space in front of the transducer. Alternatively, the beams may be 
longitudinally or transversely offset, and positioned at an angle. This configuration allows 
the use of stock transducers. It also leads to a more complex relation between the IVUS 
and IVPA imaging planes, depending on the amount of optical scattering. We explore 
both geometries in this chapter. 
Methods 
30 MHz coaxial probe 
The first prototype catheter (Figure 1) consists of a multimode optical fiber (Thorlabs, 
400 µm core diameter, low OH) to deliver the light pulses that is mounted in the central 
hole of a ring shaped lead-zirconium-titanate (PZT) ultrasound transducer (custom built 
by TU Delft; design by DuMED) for ultrasound transmission and reception. The 
ultrasound transducer has a center frequency of 30 MHz and a -6 dB bandwidth of 60%. 
A silver mirror is placed distal from the fiber tip and transducer at an angle of 45° to 
deflect both the light and ultrasound beam sideways towards the vessel wall.  
The diameter of the silver mirror is 5 mm, generating a catheter outer diameter of 
approximately the same size. This design ensures exact co-registration of the IVPA and 
IVUS images, due to the coaxial configuration of the light and ultrasound beam. 
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Figure 1. Schematic a) and pictures b) and c) of the 30 MHz coaxial probe. a) The schematic 
depicts the light path (red) and generated ultrasound signal (black arcs). Both the light pulses and 
the ultrasonic waves are reflected by the silver mirror and remain completely coaxial along their 
path. b) Photograph of catheter tip. The reflection of the optical fiber tip and the ring shaped 
transducer surrounding it are visible in the silver mirror. c) The light can be seen exiting the 
optical fiber and being deflected by the mirror under 45° angle. 
30 MHz dual beam probe 
In the second design (Figure 2), the light is deflected towards the vessel wall by 
an angle-polished optical fiber (Pioneer Optics, 400 µm core diameter, low OH). 
 
 
Figure 2. Schematic a) and pictures b) and c) of the 30 MHz dual beam probe. a) The schematic 
depicts the light path (red) and generated ultrasound signal (black arcs) b) Photograph of catheter 
tip, showing the angle polished optical fiber tip enclosed by the air filled quartz cap and the 
ultrasound transducer distal to quartz cap. c) Side view with light leaving the optical fiber tip 
under a 68° angle. 
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The fiber tip is polished under a 34° angle and covered with a glued-on quartz cap to 
preserve an air-glass interface deflecting the beam by total reflection. A lead-zirconium-
titanate (PZT) circular ultrasound transducer with a diameter of 1.0 mm (custom built by 
TU Delft; design by DuMED) for PA signal reception is placed distal from the quartz 
tube. We optically isolated the transducer with silver leaf of 4 µm thickness to eliminate 
artifacts in the PA images. The transducer is also used for generating and receiving an 
ultrasound wave for pulse-echo imaging. The optical and acoustic beams intersect at  
4.5 mm from the catheter at an angle of 22°. Figure 2b shows the light path exiting the 
probe under an angle (68°). The fiber and transducer were placed in a custom machined 
polyether ether ketone (PEEK, bio-compatible) assembly with an outer diameter of  
1.25 mm. The transducer has again a center frequency of 30 MHz and a -6 dB bandwidth 
of 60%. 
45 MHz dual beam probe 
We designed and built a second dual beam hybrid IVPA/IVUS catheter (45 MHz 
dual beam probe), utilizing the same angle–polished optical fiber but with 
a different ultrasound transducer. Photographs of the catheter are shown in Figure 3. 
 
 
Figure 3. 45 MHz dual beam probe. a) Front view photograph of probe with light exciting the 
optical fiber tip. The 0.4 x 0.4 mm PMN-PT single crystal transducer58 has a center frequency of 
44.5 MHz and a -6 dB bandwidth of 45%. b) Photograph of the catheter tip on the edge of a  
10 eurocent coin. The outer diameter of the tip is 1 mm. 
The 0.4 x 0.4 mm lead magnesium niobate-lead titanate (PMN-PT) single crystal 
ultrasound transducer was custom built by the Department of Biomedical Engineering of 
the University of Southern California58 and had a center frequency of 44.5 MHz and a  
–6 dB fractional bandwidth of 45%. Fiber and transducer were mounted in a custom 
machined stainless steel assembly with an outer diameter of 1 mm. The front of the 
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transducer was bonded to a conductive gold particle matching layer, after which an outer 
matching layer of parylene was formed by vapor deposition. The fiber tip and transducer 
center were separated by approximately 1.1 mm. The angle between the optical and 
acoustical beams was 22°; the beams overlapped between 0.5 and 4.5 mm from the 
transducer. 
Combined IVPA/IVUS imaging system 
We built an experimental imaging system to test the IVPA and IVUS imaging 
performance of the prototype catheters. The system is illustrated in Figure 4.  
 
Figure 4. Diagram of the combined IVPA/IVUS imaging system; AWG: arbitrary wave 
generator, DAQ: data acquisition, delay: pulse/delay generator; bpf: band pass filter. 
The light energy for photoacoustic imaging is delivered by a tunable laser (Opotek 
Vibrant B/355-II) It produces 5 ns high energy (> 10 mJ) light pulses in the wavelength 
range of 420 to 1800 nm with a spectral linewidth of ~ 4 - 7 cm-1 (~ 0.3 – 0.4 nm @  
800 nm; ~ 0.6 – 1 nm @ 1200 nm; ~ 1 – 2 nm @ 1700 nm) and a repetition rate of 10 Hz.  
A tapered multimode fiber (Oxford Electronics, Four Marks, UK; input diameter 1mm; 
output diameter 360 µm) couples the laser light to the catheter. An arbitrary waveform 
generator (Tabor Electronics WW2571A) transmits Gaussian-modulated cosine waves 
for pulse echo imaging. The ultrasound waves are transmitted to the probe through a 
custom-built expander and limiter. The received US and PA signals are amplified by a  
43 dB amplifier (Miteq AU1263), band pass filtered (13–60 MHz 5th order Butterworth, 
custom built) and digitized at a sample frequency of 350 MS s-1 by a 12-bit data 
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acquisition card (Acqiris DP310). A pulse/delay generator (BNC model 575) adapted 
and distributed the trigger provided by the Q-switch of the laser to the arbitrary 
waveform generator and data acquisition card. The catheter is translated and rotated by 
a motorized translational and rotary stage (Steinmeyer GmbH & Co. KG), respectively. 
Experiments 
We have tested the PA and US imaging performance of the three integrated 
IVPA/IVUS probe prototypes. For pulse-echo imaging, a 16 Vpp Gaussian modulated 
cosine wave with a center frequency of 30 MHz and a -6 dB bandwidth of 75 % was 
applied to the transducer of the first two prototype catheters; for the 45MHz dual beam 
probe, we applied a similar wave with a center frequency of 45 MHz an a -6 dB 
bandwidth of 50 %. To create images with spatially matched PA and US information, 
every light pulse was followed by 10 acoustic pulses. The received echo signals of these 
pulses were averaged to construct the US image; no averaging was applied for PA 
imaging. 
We performed measurements on isolated point targets in water at room temperature 
to determine the point spread function (PSF) widths and signal to noise ratios (SNRs) of 
the two first prototype IVPA/IVUS catheters (30MHz coaxial and 30 MHz dual beam 
probe). The point targets were formed by six evenly spaced metallic (wolfram) wires of 
50 µm diameter located at approximately 2 to 7 mm from the transducer. We acquired 
co-registered PA (800 nm) and US images of the point targets by translation of the 
catheter in steps of 50 µm and acquire a PA and US image line at every position.  
Next, using the 30 MHz dual beam probe, we imaged a cylindrical vessel phantom, 
which is shown in Figure 7c. The phantom is made of poly-vinyl-alcohol (PVA) with 
enamel as acoustic scatterers and has a 3 mm diameter lumen. Six metallic wires of 100 
µm diameter located at 1.5 to 4 mm distance from the lumen function as optical 
absorbers. We placed the phantom in water and acquired a cross-sectional scan by 
rotation of the catheter in 1 step and recording a PA and US image line at every position.  
We repeated the measurement on the isolated point targets with the 45 MHz dual 
beam probe. We then added 1 vol. % intralipid (Intralipid ® 20 %, Fresenius Kabi 
Nederland BV) to the water bath and acquired another scan of the point targets. 
Data processing 
The digitized PA data were band pass filtered between 10 and 40 MHz for the  
30 MHz probes and 10 and 70 MHz for the 45 MHz dual beam probe, using a 100th 
order zero-phase forward and reverse finite impulse response (FIR) filter. Despite the 
application of silver leaf to the transducer of the 30 MHz dual beam probe, the vessel 
phantom data were affected by an artifact caused by the absorption of laser pulses in the 
ultrasound transducer. It showed up in the IVPA images as bright rings, concealing the 
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photoacoustic signals produced by the vessel phantom close to the catheter.  
An adaptive filter was designed and applied to the IVPA data to remove this artifact.  
A similar circular artifact in the IVUS data of the vessel phantom, caused by the ‘ringing’ 
of the transducer as a result of the transmission of ultrasound pulses, was removed by 
subtracting the mean in the angular direction of the affected part of the data. All PA and 
US data were subsequently Tukey windowed and envelope filtered. The vessel phantom 
data were scan-converted to Cartesian coordinates, after which all data were log 
compressed for display. The ‘hot’ and ‘gray’ colormaps in Matlab (R2007b) were used 
for the PA and US images, respectively. To create combined PA/US images, we overlaid 
the PA data on the US images using a nonlinear red-yellow-white color scale and a linear 
transparency scale. All data processing was done using Matlab (R2007b).  
Results 
30 MHz coaxial probe 
 
 
Figure 5. Combined PA/US measurement of 
point targets using the 30 MHz coaxial probe. 
a) PA image, b) US image, and c) combined 
PA/US image. The images are noisy but there 
is perfect co-registration between the PA and 
US image. The dynamic range is 60 dB in all 
images. 
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The results of the measurements on the isolated point targets with the 30 MHz 
coaxial probe are presented in Figure 5. The PA image, shown in Figure 5a, contains 
many artifacts. The bright horizontal lines, visible up to approximately 4 mm depth, are 
the result of ultrasound pulses that are reflected back by the mirror, hitting the 
transducer. A fraction of the light may be reflected back towards the transducer as well, 
which would add to the effect. The horizontal lines are also visible in the US image, 
shown in Figure 5b, up to approximately 4.5 mm depth. In the US image, this artifact is 
superimposed on the artifact caused by the ‘ringing’ of the transducer as a result of the 
transmission of ultrasound pulses. Reverberation or ‘comet-tail’ artifacts behind the wire 
signals are present in the PA image59,60. In the combined PA/US image, presented in 
Figure 5c, the perfect co-registration of the PA and US signals in the longitudinal 
direction (along the axis of the catheter) can be seen. 
30 MHz dual beam probe 
 
A spatial mismatch can be seen between the PA and US signals from the wires closest and 
furthest away from the transducer. The dynamic range is 60 dB in all images. 
Figure 6. Combined PA/US measurement of 
point targets using the 30 MHz dual beam 
probe. a) PA image, b) US image, and  
c) combined PA/US image. Both the PA 
and US image are less noisy and have a 
better SNR than the corresponding images 
created with the 30 MHz coaxial probe. 
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Figure 6 shows the results of the measurements on the isolated point targets with the 
30 MHz dual beam probe. The PA image has less clutter than the PA image acquired 
with the 30 MHz coaxial probe. The bright lines that were seen in the coaxial probe PA 
and US images are virtually absent because the light and ultrasound are not reflected 
back to the transducer. In the US image, however, the artifact caused by the ‘ringing’ of 
the transducer as a result of the transmission of ultrasound pulses is still visible, up to 
approximately 1.6 mm depth. In both the PA and US image, a double signal from each 
point target is visible, which is caused by an incomplete damping of the ultrasound by 
the backing of the transducer. Behind the PA signal of the point targets closed to the 
transducer, comet tail artifacts are again visible. As can be seen in Figure 6c, the co-
registration of the PA and US image in the axis of the catheter is excellent between 4 and 
6 mm from the transducer, while closer to transducer the mismatch is almost 1 mm. The 
SNR is clearly higher for the PA as well as the US image when compared to the 
corresponding images obtained with the 30 MHz coaxial probe. Table 1 lists the PSFs and 
SNRs of all point target measurements. 
Table 1. Point spread function (PSF) widths and signal to noise ratios (SNRs) of all PA and US 
measurements on the isolated point targets in water and 1 vol. % intralipid (numbers in brackets). 
The axial PSF widths of the PA and US images of all three probes are in the same order of 
magnitude; the lateral PSF widths are comparable as well. All SNRs are above 50 dB, with the 
exception of the 30 MHz coaxial probe US measurement. PSF width: -6 dB point spread 
function width; SNR: signal to noise ratio. The axial PSF is averaged over the 6 wires; the lateral 
PSF and SNR are measured on the wire closest to the natural focus (at 5 mm and 2.1 mm for the 
30 MHz probes and 45 MHz dual beam probe, respectively). 
Probe Imaging 
Modality 
PSF width (µm) SNR (dB) 
axial lateral Water 
30 MHz 
Coaxial 
PA 90 450 59 
US (10x) 56 275 39 
30 MHz 
dual beam 
PA 100 300 58 
US (10x) 61 400 52 
45 MHz 
dual beam 
PA 77 (50) 525 (350) 57 (57) 
US (10x) 87 (45) 225 (200) 60 (62) 
 
The IVPA and IVUS image of the vessel phantom created with the 30 MHz dual 
beam probe are presented in Figures 7a and 7b, respectively. All 6 wires are clearly 
visible in both images. The circular artifacts, mentioned in the Methods section, are 
effectively suppressed, revealing the data close to the transducer. Comet tail artifacts 
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can be seen behind the two point targets closest to the transducer. The combined 
IVPA/IVUS image (Figure 7d) shows the perfect overlap of the PA and US wire signals in 
the transverse direction (perpendicular to the axis of the probe).  
 
Figure 7. Cylindrical vessel phantom, imaged with the 30 MHz dual beam probe. a) IVPA image 
(dynamic range 45 dB), and b) IVUS image (dynamic range 50 dB) of the phantom.  
c) Photograph of the phantom, taken from the top. d) Combined IVPA/IVUS image.  
45 MHz dual beam probe 
The results of the 45 MHz dual beam probe measurements of the isolated point 
targets are presented in Figure 8. The horizontal lines in the PA image are caused by 
photoacoustic signals generated in the catheter tip. In the US image, the ‘ringing’ of the 
transducer is again visible. In the PA image, the comet tail artifacts can be clearly 
discerned behind the first four point targets. The combined PA and US image of the point 
target measurement in water is shown in Figure 8c. The PA and US signals overlap 
between 2 and 4 mm from the transducer (wire 2 and 3), while closer to and further 
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away from transducer the signals are misaligned. Introduction of light scattering by 
adding 1 % vol. intralipid to the water bath, yields perfect co-registration of all PA and US 
wire signals (Figure 8d), without lowering the SNR significantly (Table 1). While a 
comparable SNR at the natural focus distance is found for all catheters, the SNR of the 
45 MHz dual beam probe falls sharper with depth, due to the higher ultrasound 
attenuation at higher frequencies. 
 
Figure 8. Combined PA/US measurement of point targets using the 45 MHz dual beam probe.  
a) PA image, b) US image, and c) combined PA/US image of measurement in water. A spatial 
mismatch can be seen between the PA and US signals from the wires closest and furthest away 
from the transducer. d) PAUS 1% vol. intralipid. The dynamic range is 60 dB in all images. 
Discussion 
We presented three prototype integrated optical/acoustic catheters for combined 
IVPA/IVUS imaging: one 30 MHz coaxial probe and 30 and 45 MHz dual beam probes. 
We characterized their imaging performance using a point target phantom. We found PA 
and US axial PSF widths equal to or less than 100 µm and lateral PSF widths at the 
natural focus distance between 200 and 550 µm. The SNRs at the natural focus distance 
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ranged from 52 to 62 dB, with the exception of the US SNR of the coaxial probe, which 
was only 39 dB. The coaxial design suffered from artifacts in the PA and US images due 
to the reflection of the ultrasonic waves and possibly the absorption of light energy at the 
mirror surface. We demonstrated good imaging performance of the 30 MHz dual beam 
probe on a cylindrical vessel phantom containing metal wires as optical absorbers.  
For the coaxial probe design it is imperative that the mirror is placed as close as 
possible to the optical fiber tip to minimize the length of light path through water and 
thus the water absorption. This is especially important at longer wavelengths in the near-
infrared, where the high water absorption limits the penetration depth. Furthermore, to 
avoid damage to the mirror in the PA image, the material of the mirror needs to have a 
high damage threshold and thus a low absorption coefficient in the wavelength range of 
interest. 
Based on the results presented here and, we elected the dual beam design for future 
prototype catheters. The design will be further improved to fully eliminate the PA 
artifacts due to incompletely optical isolation of the ultrasound transducer. We will 
fabricate the catheter tip of future prototype catheters out of PEEK to minimize the 
generation of photoacoustic waves in the catheter tip. The small size of the USC 
ultrasound transducer allows for further reduction of the catheter diameter to the 
desired dimension of 0.7 mm. However, the optical fiber diameter will have to be 
reduced as well to attain this objective. This will require an adjustment of the light 
coupling to the catheter and ultimately a different light source.  
 
  
  
 
Chapter  4 
 
Intravascular 
photoacoustic imaging 
of human coronary 
atherosclerosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the publication by Krista Jansen, Antonius FW van der Steen, Heleen MM van 
Beusekom, J Wolter Oosterhuis, and Gijs van Soest, Intravascular photoacoustic imaging 
of human coronary atherosclerosis, Optics Letters, 36 (2011) 597-599.
CHAPTER 4 
44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
We demonstrate intravascular photoacoustic imaging of human coronary 
atherosclerotic plaque. The data was obtained from two fresh human coronary arteries 
ex vivo, showing different stages of disease. A 1.25 mm diameter intravascular imaging 
catheter was built, comprising an angle-polished optical fiber adjacent to a 30 MHz 
ultrasound transducer. Specific photoacoustic imaging of lipid content, a key factor in 
vulnerable plaques that may lead to myocardial infarction, is achieved by spectroscopic 
imaging at different wavelengths between 1180 and 1230 nm. Simultaneous imaging with 
intravascular ultrasound was performed.  
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The majority of acute coronary events are precipitated by the rupture of a vulnerable 
atherosclerotic plaque in the coronary system, and subsequent thrombogenesis4,61. 
Among the parameters that influence plaque vulnerability are the presence of a lipid-rich 
necrotic core, the thickness of the fibrous cap overlying that core, inflammation, and 
intraplaque hemorrhage3. The key to plaque vulnerability is still elusive, even though 
recent advances in intravascular imaging technology have enabled the collection of a 
wealth of data on unstable atherosclerosis in all its stages of development62, both in 
clinical and in ex vivo settings. Plaque type and morphology are relevant for intervention 
planning, and significantly affect long term treatment outcome63. 
The present standard for intravascular diagnostic imaging is intravascular ultrasound 
(IVUS)64. It images the lumen geometry and the structure of the vascular wall with a 
resolution of approximately 100 µm. IVUS clearly shows the presence of calcified tissue, 
but has a limited specificity for different soft tissue types65. Recently, a device combining 
IVUS with near-infrared reflection spectroscopy (NIRS) was demonstrated31. This 
technology marks the lipid-containing sectors of the IVUS image with the aim to detect 
lipid-core plaques. It has no depth sensitivity, however: NIRS can identify the presence 
but not the amount or the position of the lipid concentration relative to the lumen. 
Intravascular photoacoustics (IVPA) is a tool for plaque composition imaging. Like 
NIRS, it capitalizes on the differences in the chemical absorption spectra of various tissue 
types: by selecting the excitation wavelength, a photoacoustic signal can be excited from 
specific tissue types in the artery wall. Wang et al. applied this principle to imaging lipid 
in atherosclerotic rabbit aorta, using a bench-top setup with external illumination near 
1200 nm44. Allen and Beard studied human aorta samples, outlining the spectral 
difference between lipid-rich and normal vascular tissue45. Several designs for 
IVPA/IVUS probes have been proposed55,56,60, but these have not been applied to actual 
atherosclerotic tissue.  
In this paper we demonstrate imaging of human atherosclerotic arteries ex vivo with 
a custom-built IVPA/IVUS catheter. The imaging capability of the device is 
demonstrated, unveiling prominent disease features in a human coronary lesion that 
shows hallmarks of a vulnerable plaque. 
A hybrid IVPA/IVUS catheter was built (Figure 1a), consisting of a 400 µm diameter 
core optical fiber (Pioneer Optics, Bloomfield, CT) and a lead-zirconium-titanate (PZT) 
ultrasound transducer with a diameter of 1.0 mm (custom built by TUDelft; design by 
DuMED, Rotterdam). The tip of the fiber was polished at an angle of 34° and covered 
with a glued-on quartz cap to preserve an air-glass interface deflecting the beam by total 
reflection. The transducer had a center frequency of 30 MHz and a 6-dB fractional 
bandwidth of 65%. Fiber and transducer were mounted in an assembly with an outer 
diameter of 1.25 mm; see Figure 1b.  
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Figure 3: a) Diagram of the experimental setup, including a detailed schematic of the catheter tip, 
showing the beam layout; AWG: arbitrary wave generator, DAQ: data acquisition, exp: expander, 
lim: limiter, bpf: band pass filter, amp: amplifier. b) Photograph of the catheter tip on the edge of 
a 10 eurocent coin. 
The fiber tip and transducer center were separated by approximately 1 mm. The angle 
between the optical and acoustical beams is 22˚; the beams overlap between 0.5 and  
4.5 mm from the transducer. Our catheter is comparable in design to the one discussed 
in55 but is about half the size in diameter. 
Coronary arteries were obtained from the Dept. of Pathology of the Erasmus MC at 
autopsy and imaged within 24 h post mortem. Consent was obtained from the relatives 
and the protocol was sanctioned by the Medical Ethics Committee of the Erasmus MC.  
The specimens were mounted on two cannulas in a tank containing saline solution. 
Large side branches were closed and arteries were pressurized to 100 mmHg to maintain 
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an open lumen. The arteries were screened by an IVUS pullback (Boston Scientific iLab, 
Atlantis SR Pro catheters) and sites of interest were marked with suture needles. 
Markers were located with IVPA for further data acquisition.  
After imaging the artery specimens were cut at the image plane. The segments 
proximal from the image plane were fixed in 4% buffered formaldehyde, paraffin 
embedded, and serially sectioned at the imaging plane for histology; segments distal 
from the imaging plane were frozen in isopentane and sections prepared for lipid staining 
(Oil Red O). 
 
Cross-sectional scans at sites of interest were made by rotation of the catheter in  
1° steps using a motorized rotary stage (Steinmeyer GmbH & Co KG). At every position 
IVPA and IVUS image lines were acquired, ensuring image co-registration. Pulse echo 
imaging was performed using an arbitrary waveform generator (Tabor Electronics 
WW2571A) transmitting a Gaussian-modulated cosine wave (30 MHz; 10 Vpp; 100% 
bandwidth). A tunable laser (OPOTEK Vibrant B/355-II) provided the excitation light 
(pulse width 5 ns, repetition rate 10 Hz, pulse energy 1.2 mJ at catheter tip) for 
photoacoustic imaging. Images were acquired at several excitation wavelengths between 
715 and 1800 nm. We concentrated on the spectral range near 1200 nm where a 
prominent harmonic of the C—H stretch vibrational mode signals the presence of 
lipids38,66. In addition, full spectral scans were made at particular angular locations, which 
were selected based on IVUS morphology. All received IVUS and IVPA signals were 
band-pass filtered, amplified (Miteq AU1263), and digitized (Acqiris DP310).  
No averaging was applied for IVPA imaging; IVUS traces were averaged 10-fold. 
Acquisition of one IVPA/IVUS image took 36 s. The dynamic range of all IVUS and IVPA 
images shown in this paper is 40 dB.  
 
IVPA/IVUS was performed in an advanced lesion (left anterior descending artery, 
male aged 56). The results are shown in Figure 2. The histology shows circumferential 
intimal thickening with a large eccentric lipid-rich lesion, as well as a calcified area and 
regions of peri-adventitial fat. The IVUS data confirms this morphology. The IVPA image 
at 1210 nm exhibits a bright signal along the intimal border, and also from deeper tissue 
layers in the eccentric plaque and the peri-adventitial fat in the bottom right corner.  
At 1230 nm the signal is markedly lower, in accordance with the absorption spectrum of 
lipids in this wavelength range. Collocated with the enhanced 1210 nm IVPA signal a 
positive Oil Red O stain is observed, particularly in the plaque, indicating the presence of 
lipids. Variation in the laser pulse energy and tissue scattering properties is negligible 
over the wavelength range 1210 to 1230 nm.  
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 Figure 2. IVPA/IVUS imaging of an advanced human atherosclerotic plaque. a) Histology: Oil 
Red O stain shows the presence of a lipid rich plaque () as well as a calcified area (Ca);  
Lu: lumen, Pf: peri-adventitial fat. b) IVUS image, IVPA images at c) 1210 nm (high lipid 
absorption) and d) 1230 nm (low lipid absorption). Arrowheads indicate the needle used for 
marking. Full spectral scans were made along the white line in c) and d). The spectra at the 
locations marked by the white dots are shown in Figure 3. 
 
 
Photoacoustic spectra were acquired along image lines sampling the plaque tissue. 
The resulting data sets are two-dimensional matrices of wavelength vs. depth. In  
Figure 3, spectra are shown at three locations, two inside the lipid-rich plaque region and 
one just outside. Absorption spectra of lipids and connective tissue38 are included for 
reference. The two spectra located in the plaque clearly match the lipid reference, while 
the third clearly lacks the pronounced peak. 
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Figure 3. Photoacoustic spectra at 3 locations on the white line shown in Figure 2d. The sites at 
1.4 mm and 1.7 mm distance from the catheter are located within the lipid rich plaque.  
The corresponding PA spectra show strong resemblance to the lipid absorption reference.  
The site at 2.2 mm is located just outside the plaque area. 
 
 
Spectroscopic imaging is demonstrated on a second specimen (left main stem, 
female aged 43). The results are shown in Figure 4. The IVUS image of this cross section 
shows mild fibrous intimal thickening. Comparison of the combined IVPA/IVUS images 
at 1210 and 1230 nm shows the presence of lipids outside the vessel wall; this peri-
adventitial fat is part of the normal anatomy. The average IVPA signal strength in this 
region, acquired from IVPA images at various wavelengths between 1180 and 1230 nm, 
closely tracks the lipid absorption peak shape.  
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Figure 4. Combined IVPA/IVUS image at a) 1210 nm and b) 1230 nm of a healthy human 
coronary artery. c) Average IVPA signal strength in the area indicated in a and b, obtained from 
images at wavelengths between 1180 nm and 1230 nm, closely tracks the peak in the reference 
lipid absorption spectrum. 
The design of a small diameter IVPA probe and the successful imaging of the lipid 
content of a human atherosclerotic plaque ex vivo demonstrated in this paper are 
important steps toward the realization of in vivo IVPA imaging. Two factors that prevent 
immediate translation to in vivo imaging are the diameter of our probe and the repetition 
rate of the laser. While our catheter is the smallest IVPA probe to date, it needs to be 
reduced to < 1 mm for clinical imaging. In vivo imaging at a frame rate of 20 images per 
second requires a significantly faster excitation source. 
We have demonstrated specific imaging of lipids in ex vivo human coronary plaques. 
By combining data at different wavelengths in the lipid absorption spectrum, this key 
component of vulnerable plaques can be identified. By its hybrid optical/acoustic nature, 
IVPA is a natural addition to IVUS and extends its imaging capability with tissue type 
sensitivity.  
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Abstract 
The natural history of atherosclerosis is marked by changes in the lipid biochemistry 
in the diseased arterial wall. As lesions become more vulnerable, different cholesterol 
species accumulate in the plaque. Understanding unstable atherosclerosis as a 
pharmacological and interventional therapeutic target requires chemically specific 
imaging of disease foci. In this study, we aim to image atherosclerotic plaque lipids and 
other vessel wall constituents with spectroscopic intravascular photoacoustics (sIVPA). 
sIVPA imaging can identify lipids in human coronary atherosclerotic plaque by relying on 
contrast in the near-infrared absorption spectra of the arterial wall components. Using 
reference spectra acquired on pure compounds, we analyzed sIVPA data from human 
coronary plaques ex vivo, to image plaque composition in terms of cholesterol and 
cholesterol ester content. In addition, we visualized the deeper lying connective tissue 
layers of the adventitia, as well as the fatty acid containing adipose cells in the peri-
adventitial tissue. We performed simultaneous co-registered IVUS imaging to obtain 
complementary morphological information. Results were corroborated by 
histopathology. sIVPA imaging is capable of distinguishing the most important lipid 
components of human atherosclerotic plaques: cholesterol and the two most prominent 
cholesterol esters, cholesterol oleate and cholesterol linoleate. It can also visualize the 
connective tissue layers of the adventitia and the fatty acid containing adipose cells in 
the peri-adventitial tissue.  
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Atherosclerosis is a chronic cardiovascular disease characterized by inflammation 
and lipid accumulation in the vessel wall. Myocardial infarctions are a leading cause of 
death worldwide1. In the majority of cases, myocardial infarctions and strokes are caused 
by the rupture of an atherosclerotic plaque and the subsequent release of its 
thrombogenic content into the bloodstream2. The term “vulnerable plaque” has been 
coined to indicate a plaque at high risk of rupture that could lead to thrombosis3.  
The susceptibility of a plaque to rupture – its vulnerability - is known to be related to 
plaque composition, mechanical stress distribution, inflammatory state3,4 and presence 
of positive remodeling67. A prominent type of vulnerable plaque is the thin-cap 
fibroatheroma (TCFA). These lesions are characterized by a lipid-rich necrotic core 
covered by a thin fibrous cap that is weakened by macrophage infiltration and decreased 
smooth muscle cell content7.  
The chemical composition of the lipid core is related to the age and stability of a 
lesion. Starting as a foam cell rich lesion (fatty streak) that contains cholesterol esters, 
supersaturation leads to cholesterol crystallization and cell death resulting in a more 
complex atherosclerotic plaque containing a necrotic core68. The necrotic core contains 
cholesterol crystals and extracellular droplets of cholesterol esters. At the periphery of 
the lesion, cholesterol esters in foam cells dominate69. The esterified lipid concentrations 
at the edge of advanced plaques often coincide with an increased macrophage activity 
and decreased cap thickness, leading to a predisposition to rupture69. A concurring 
degradation of the supporting structure in the necrotic core enables its thrombogenic 
content to freely flow into the bloodstream upon of rupture of the cap68.  
During plaque regression, for instance due to cholesterol lowering drugs or lifestyle 
changes, cholesterol ester content and numbers of foam cells and macrophages 
decrease. The lipid content of the cells is deposited in cholesterol crystals and the 
relative proportion of free cholesterol increases. Prolonged regression returns the lipid 
content of the artery wall towards normal, slowly dissipating the cholesterol crystals, and 
results in a lipid-poor but scarred intima70. Interestingly, the cholesterol ester spectrum 
differs between developing and regressing lesions68.  
Temporal lipid content and composition changes of atheromatous plaques are a 
hallmark of atherosclerotic disease stage. Established techniques are unable to positively 
identify and quantify lipid content, or to distinguish between lipid types present in 
atherosclerotic plaques. Catheter-based near-infrared reflection spectroscopy (NIRS) 
uses optical absorption to signal the presence of lipid-core plaque in the coronary wall. It 
is, however, a sensing technology which cannot locate the position of the lipid-core 
relative to the lumen boundary32. By combining NIRS with intravascular ultrasound 
(IVUS), the most commonly used intravascular imaging technology in clinics worldwide, 
morphological information is added but lipid mapping still lacks depth resolution31. Other 
imaging modalities, like IVUS, optical coherence tomography (OCT), or X-ray computed 
tomography (CT), rely on backscatter and signal attenuation to interpret images in terms 
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of tissue type71-73. In IVUS, percent atheroma volume (PAV) is the most commonly 
applied imaging markers for plaque regression74,75. A modality that can assess plaque 
composition and morphology addresses multiple needs in cardiovascular medicine.  
It provides a chemical imaging biomarker that may acquire a role in clinical trials of drug 
or device therapies, to grade and monitor plaque regression. By the same merits, such a 
technique is a likely candidate to attain a prospective definition of vulnerable plaque,  
a diagnostic criterion that has been elusive since the concept was proposed7,76,77. 
Photoacoustic (PA) signals are generated in tissue when the absorption of short laser 
pulses causes the tissue to thermo-elastically expand. Since PA signals are acoustic 
waves, they can be recorded in the same manner as the pulse-echo ultrasound waves78. 
Intravascular photoacoustic (IVPA) imaging is a catheter-borne version of PA imaging.  
It uses the intrinsic contrast in optical absorption between tissue types to visualize 
different constituents of atherosclerotic plaques. IVPA has been demonstrated to 
distinguish calcified plaque42, atheroma40,41, and more specifically lipids44,46,79 from 
healthy vessel wall, as well as the presence of macrophages through the use of 
exogenous contrast agents50.  
We demonstrate that spectroscopic intravascular photoacoustic (sIVPA) imaging is 
capable of distinguishing the most important lipid components of atherosclerotic 
plaques: cholesterol and the two most prominent cholesterol esters, cholesterol oleate 
and cholesterol linoleate. In addition, we visualize the deeper lying connective tissue 
layers of the adventitia, as well as the fatty acid containing adipose cells in the peri-
adventitial tissue. We performed simultaneous co-registered IVUS imaging to obtain 
complementary morphological information. We first determined the PA spectra of 
cholesterol, cholesterol oleate (CE18:1) and linoleate (CE18:2) to use as reference 
absorption spectra of lipids present in atherosclerotic lesions. These are primarily 
enhanced as atherosclerosis progresses and detailed absorption spectra are currently 
not available for these substances. 
We then conducted spectroscopic photoacoustic imaging of human coronary arteries 
ex-vivo and show detailed local spectra of the different tissue constituents of the 
atherosclerotic vessel wall, demonstrating the ability of spectroscopic photoacoustic 
imaging to differentiate lipid types as well as connective tissue. For this purpose, we built 
an integrated photoacoustic and ultrasound imaging system capable of simultaneous, 
co-registered imaging of human coronary arteries ex-vivo. Histopathology of the imaged 
artery cross sections was performed to corroborate our findings. 
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Methods 
Integrated catheter and system for intravascular imaging  
We designed and built a hybrid IVPA/IVUS catheter, see Figure 1. The design is 
similar to devices we used in earlier work79,80. It comprised a 400 µm diameter core 
optical fiber (Pioneer Optics, Bloomfield, CT) to deliver light pulses to the vessel wall and 
a lead magnesium niobate-lead titanate (PMN-PT) single crystal ultrasound transducer 
(custom built58) to send and receive ultrasound waves. The tip of the fiber was polished 
at an angle of 34° and covered with a glued-on quartz cap to preserve an air-glass 
interface deflecting the beam by total reflection. The transducer had a center frequency 
of 44.5 MHz and a –6 dB fractional bandwidth of 45%. Fiber and transducer were 
mounted in an assembly with an outer diameter of 1 mm. The fiber tip and transducer 
center were separated by approximately 1.1 mm. The angle between the optical and 
acoustical beams was 22°; the beams overlapped between 0.5 and 4.5 mm from the 
transducer. The imaging performance of the catheter is shown in Figure 2. We used this 
catheter to perform the PA spectroscopy measurements of cholesterol and cholesterol 
derivates. Imaging of arteries was performed with the device described in Jansen et al.79 
The catheter was connected to a spectroscopy/imaging system79. A tunable laser 
(Vibrant B/355-II, OPOTEK, Santa Clara, CA, USA) provided the excitation light (pulse 
width 5 ns, repetition rate 10 Hz, pulse energy 1.2 mJ at catheter tip) for photoacoustic 
imaging. An arbitrary waveform generator (WW2571A, Tabor Electronics Tel Hanan, 
Israel) transmitted a Gaussian-modulated cosine wave for pulse echo imaging, which 
was transmitted to the probe through a custom-built expander and limiter. The received 
US and PA signals were band pass filtered (13–60 MHz 5th order Butterworth, custom 
built), amplified by a 43 dB amplifier (AU1263, Miteq, Hauppauge, NY, USA) and 
digitized at a sample frequency of 350 MS s-1 by a 12-bit data acquisition card (Acqiris 
DP310, Agilent, Santa Clara, CA, USA). A schematic of the experiment and photos of the 
catheter are shown in Figures 1a-1c. 
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Figure 1. Combined IVPA and IVUS imaging. a) The intravascular IVPA/IVUS catheter is 
inserted in an ex vivo human coronary artery and rotated in 1° steps. Laser pulses for IVPA 
imaging and electric pulses for pulse echo (IVUS) imaging are delivered to the vessel wall 
interleaved at every angular position. b) Photograph of the catheter tip on the edge of a  
10 eurocent coin. White arrow indicates 1 mm. c) Photograph of the catheter tip, showing the 
light beam exiting the catheter. d) Photograph of artery in setup, side view. On the left,  
the translation (x) and rotary stage are visible. 
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Figure 2. Imaging performance of the combined intravascular photoacoustic and ultrasound 
probe. a) Impulse response and b) its frequency spectrum measured with a needle hydrophone 
(75μm tip, calibrated from 2 to 60 MHz, Precision Acoustics, LTD) in the far field, at 2.3 mm 
(excitation pulse: monocycle negative impulse, -5 V peak negative, 43 dB amplification). c) Beam 
profile, d) maximum intensity vs. axial distance, and e) lateral beam profile at the natural focus, 
measured with the same needle hydrophone (excitation pulse: Gaussian modulated sine, center 
frequency 44.5 MHz , 44.5% -6dB bandwidth, 10 Vpp, 43 dB amplification). f) 1205 nm IVPA, 
and g) IVUS image (excitation pulse: Gaussian modulated sine, center frequency 44.5 MHz, 50% 
-6 dB bandwidth, 10 Vpp, 43 dB amplification) of a 15 μm diameter metallic wire at 3 mm from 
the transducer. 
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Cadaver coronary artery acquisition and handling  
We obtained coronary arteries from the Department of Pathology of the Erasmus MC 
at autopsy and imaged them within 24 h post mortem. Consent was obtained from the 
relatives and the protocol was sanctioned by the Medical Ethics Committee of the 
Erasmus MC (MEC-2007-081).  
The specimens were mounted on two cannulas in a tank containing saline solution. 
Large side branches were closed and arteries were pressurized to 100 mmHg to maintain 
an open lumen. A photograph of an artery mounted in the setup is shown in Figure 1d. 
Combined photoacoustic and ultrasound imaging of human coronary 
arteries  
The cadaveric coronary arteries were imaged at room temperature within 24 h post 
mortem. We performed an IVUS pullback of the arteries (iLab system with Atlantis SR 
Pro catheters; Boston Scientific, Fremont, CA, USA) to find sites of interest, and marked 
them using suture needles. The combined IVPA/IVUS catheter was mounted in a 
rotation/translation stage (Steinmeyer, Albstadt, Germany; see Figure 1d. The suture 
needles were located and at these sites co-registered IVPA and IVUS cross-sectional 
scans were made. 
Optical and ultrasound transmissions alternate for exactly coregistered data 
acquisition, as illustrated in Figure 1a. This procedure results in IVPA and IVUS images of 
the arterial cross section, as shown in Figures 2a and 2b, respectively. The image shown 
here was acquired at 1210 nm. The IVUS and IVPA data sets may be overlaid to create a 
compound display (Figure 3c). Spectral scans were made at selected angles. One scan 
results in a two-dimensional data matrix, shown in Figure 3d, containing the PA spectra 
at the different distances from the catheter. Local absorption spectra can be extracted, 
as shown in Figure 3e. Histology (Oil Red O stain; Figure 3f) confirms the presence of 
lipids in the areas with a high photoacoustic signal at 1210 nm. 
The ultrasound images were created in conventional pulse-echo mode. We 
transmitted a 10 V peak to peak Gaussian-modulated cosine wave with a center 
frequency of 30 MHz and a 100% –6 dB bandwidth. Two-dimensional images were 
obtained by rotating the catheter in 1° steps and repeating the ultrasound pulse-echo 
measurement in every direction. 
IVPA images were acquired at several excitation wavelengths around 1200 nm. No 
averaging was applied for IVPA imaging; IVUS traces were averaged 10-fold. Digitized 
IVPA and IVUS data were band pass filtered (10–40 MHz 300th order zero-phase 
forward and reverse finite impulse response [FIR] filter), Tukey windowed, enveloped 
and log compressed. The data were then converted to Cartesian coordinates and 
displayed using the ‘hot’ and ‘gray’ colormaps in Matlab (The Mathworks, Natick, MA, 
USA) for the IVPA and IVUS images, respectively. Combined IVPA/ IVUS images were 
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created by overlaying the IVPA data on IVUS image using a nonlinear red-yellow-white 
color scale and a linear transparency scale. All data processing was done using Matlab 
R2007b. 
 
 
Figure 3. Spectroscopic IVPA imaging. Co-registered IVPA and IVUS data are processed to 
create IVPA a), IVUS b) and combined IVPA/IVUS c) images. At selected angular positions, 
indicated by the green line, 2D spectral IVPA d) data are recorded by changing the wavelength of 
the light while keeping the catheter at rest. e) Spectra at several locations in the vessel wall are 
extracted f) IVPA and IVUS images are matched to histology stains for tissue characterization. 
Scale bars indicate 1 mm. Dynamic range of IVPA and IVUS images is 28 dB. 
PA spectroscopy of cholesterol and cholesterol derivates  
A small volume of lipid material (cholesterol, cholesterol oleate and cholesterol 
linoleate; all from Sigma Aldrich Chemie BV, Zwijndrecht, The Netherlands) was 
positioned directly in front of the catheter tip. They were contained in a holder, made of 
TPX and designed to minimize acoustic reflections. We recorded spectral PA data by 
recording the signal trace generated by the lipids at wavelengths between 1125 nm and 
1275 nm, spaced by 2 nm. This procedure resulted in a two-dimensional data set as in 
Figure 3d. The differences in molecular structure between the three cholesterol species 
are illustrated in Figure 4. 
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Figure 4. The molecular structure of the main lipid species in atherosclerotic lesions. Molecular 
structures of a) cholesterol oleate (C45H78O2), b) cholesterol (C27H46O) and c) cholesterol 
linoleate (C45H76O2).  
The magnitude of the locally generated PA signal is dependent on the local fluence, 
the absorption coefficient and the Grüneisen parameter of the tissue. The Grüneisen 
parameter, representing the thermo-acoustic efficiency, is dependent on the sound 
speed, the thermal expansion coefficient and the specific heat at constant pressure.  
It therefore varies between different tissue types. Since the differences in local fluence 
are negligible within a small wavelength range, local variations in the PA signal amplitude 
with wavelength can be interpreted as changes in the absorption coefficient.  
We concentrated on the spectral range near 1200 nm where a prominent harmonic of 
the C—H stretch vibrational mode signals the presence of lipids66. Moreover, we take 
advantage of the fact that the absorption spectrum of connective tissue is markedly 
different from that of lipids in this wavelength range, while the absorption of water is 
relatively low. We analyzed the data and determined the 32 times averaged normalized 
PA spectra for the three lipids. 
Robustness of the spectra was investigated by studying the individual variations in 
single-shot spectra, and monitoring the spectral shape for different depths in a sample. 
The stability of the spectrum was evaluated by repeating the measurement several times 
over 75 minutes. 
PA spectroscopy of human coronary arteries  
At each imaging location, in addition to the IVPA/IVUS images acquired at several 
excitation wavelengths, full spectral scans were made at particular angular locations, 
which were selected based on IVUS morphology. Spectral PA data were recorded from 
715 to 1800 nm with 5 nm steps. The data were then processed, as illustrated in Figure 5. 
After the bandpass filtering operation described above, we selected regions containing 
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the tissue and reference signals. The reference data contain non-saturated signal close to 
the catheter that is due to light absorption in the catheter, which generates an artifacts. 
The amplitude of this signal was used to correct for variations in light intensity. 
Subsequently, the data were upsampled, jitter corrected, and downsampled to the 
original sample frequency. The data in the signal region was then Tukey windowed and 
corrected for variations in the light intensity using the jitter corrected reference data.  
We extracted the envelope of the tissue signal. Next, locations of high signal intensity 
were chosen automatically by selection of all peaks above a certain threshold in the  
1195 nm enveloped signal trace. Spectra at those locations were noise filtered using a 
fourth order digital smoothing polynomial (Savitzky-Golay; SG) filter. 
Histopathology of the atherosclerotic human arteries  
After imaging, the arterial specimens were cut at the imaging plane and serially 
sectioned for histology staining. The segment proximal from the image plane was fixed in 
4% buffered formaldehyde and embedded in paraffin. The tissue block was serially 
sectioned (5 µm thickness) at the imaging plane and stained by Hematoxylin-Eosin 
(H&E) and Resorcin-Fuchsin (RF). The segment distal from the imaging plane was 
embedded in optimal cutting temperature (OCT) compound (Tissue-Tek®, Sakura 
Finetek Europe B.V.), frozen in isopentane vapor at 77K, and stored at –80 ˚C until serial 
sectioning (20 µm thickness) for Oil Red O (ORO) and H&E. Tissue sections were 
viewed and digitized using a whole-slide scanner (Nanozoomer, Hamamatsu Photonics, 
K.K.). The ORO staining identifies lipids (stained red). The H&E stained sections were 
used to assess tissue morphology. 
 
Results 
PA spectroscopy of cholesterol and cholesterol derivates 
Measurement of the photoacoustic signal of cholesterol, cholesterol oleate and 
cholesterol linoleate in the 1200 nm range yielded three distinct photoacoustic spectra 
(Figure 6). The absorption features in this wavelength range are caused by the second 
overtones of the vibrational modes of the C-H bonds in the molecules38,66. Wavelength 
shifts and intensity changes between the spectra of cholesterol, cholesterol oleate and 
cholesterol linoleate originate from the differences in their molecular structures: the 
cholesterol esters have a fatty acid tail that consists mainly of CH2 groups (Figure 4). 
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Figure 5. sIVPA data processing to obtain depth-resolved IVPA spectra. a) Band pass filtered PA 
traces at different wavelengths. Regions containing the tissue (bottom rectangle) and reference 
(top rectangle) signals, are indicated. b) Upsampling and jitter correction. c) Light intensity 
corrected data in the tissue signal region with colored circles marking peaks above a certain 
threshold in the signal envelope of the PA trace at 1195 nm. d) Resulting spectra at those sites 
after noise filtering. 
 
The two highest peaks at approximately 1196 nm (1192 nm for cholesterol) and  
1210 nm are associated with the asymmetrical stretching modes of the methyl (CH3) 
and methylene (CH2) group vibrations, respectively, while the symmetrical stretching 
modes of the same groups are visible only as a shoulder or inflection points around  
1151 nm and 1167 nm, respectively81. 
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The robustness of the recorded spectra was evaluated by studying the reproducibility 
of spectra without averaging and by comparing averaged sets at different depths.  
Figure 5 summarizes the results of these experiments for one of the pure lipid 
compounds investigated. In Figure 7a the difference between unaveraged spectra is 
shown to be very small, in the order of a few percent of the total signal. We attribute the 
remaining variation to measurement noise that is not adequately smoothed by the SG 
filter. Likewise, the spectra acquired at different depths are very similar (Figure 7b).  
 
The stability of the absorption spectrum over time is demonstrated by the data in 
Figures 5c and 5d: we see a moderate increase in signal strength, but no change in 
spectral shape. The change in signal amplitude may be attributed to variations in packing 
density and water content in the lipid sample. Over time, the (unsaturated) lipid in the 
container is likely to be oxidized. We see that the spectrum appears to be robust against 
such variations. 
IVPA spectroscopy of human coronary arteries 
We performed dual-modality imaging of a human coronary atherosclerotic artery 
(left anterior descending artery, male aged 56) ex vivo. Co-registered IVPA and IVUS 
data was obtained at multiple cross-sections. The data were processed to obtain 
combined IVPA/IVUS images (Figure 8a). The artery was then cut at the imaging plane 
and serially sectioned for histology staining (Figure 8b). 
Histology exhibited a large eccentric lipid-rich lesion containing a calcification, and a 
circumferentially thickened, lipid-laden intima. The artery was embedded in peri-
adventitial fat. While the IVUS image confirmed the morphology of the artery as shown 
in Figure 8a, the 1210 nm IVPA image overlaid on it displayed regions of high PA signal 
intensities that correspond to the lipid rich regions. 
 
Figure 4. Absorption spectra of 
cholesterol, cholesterol oleate and 
cholesterol linoleate in the 1200 nm 
wavelength region as recorded by 
photoacoustic spectroscopy exhibit 
clear differences. 
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Figure 7. Robustness of lipid PA spectroscopy, showing data from cholesterol linoleate as  
an example. a) Comparison of “single-shot” spectra. b) Spectra obtained at different depths.  
c) Evolution of the spectral amplitude over time. d) Data from panel c after normalization. 
 
Positive confirmation of the presence and identification of lipids requires wavelength-
dependent measurement. In the two directions indicated by the white lines, labeled # 
and *, in the IVPA/IVUS image, we acquired spectroscopic IVPA data. Spectra in tissue 
were composed from one single IVPA acquisition per wavelength, creating a data set as 
in Figure 3d, and then plotting the signal strength as a function of wavelength at a single 
pixel in depth. We show the IVPA spectra of different tissues in Figure 8. 
The first direction (#) contained atherosclerotic plaque (Figure 8c), while the second 
line-of-sight (*) intersected with the lipid-rich diseased intima (Figure 8d), the adventitia 
(Figure 8g) – the outermost layer of the vessel wall consisting of connective tissue – and 
a region of peri-adventitial tissue (Figure 6h) composed mainly of adipocytes (fat cells) 
containing fatty acids38.  
 
INTRAVASCULAR PHOTOACOUSTIC IMAGING OF HUMAN CORONARY ATHEROSCLEROSIS
65 
 
Figure 8. IVPA spectra of a human atherosclerotic coronary artery, ex vivo. a), Dual-modality 
IVPA/IVUS image, arrowhead indicates suture needle. Along the white lines (# and *), spectral 
IVPA data were obtained. Normalized IVPA spectra at the locations of the dots are shown in  
c), d) g), and h), compared to absorption spectra obtained in Figure 6 and reference spectra for 
collagen, elastin and fatty acids from literature38. b) Histology section of the site imaged in a, 
showing near circumferential intimal lipid accumulation (red) and presence of a calcification (Ca). 
The lipid rich core (#) and pathological intimal thickening (PIT; *) are magnified (3x) in e) and  
f) showing the locations where the IVPA spectral data are recorded. Oil Red O stain,  
Lu = lumen, PL = peri-adventitial lipid, Ca = Calcium, bar = 1 mm. i) Hematoxylin-Eosin 
(H&E) histologic stain of the area #, showing reduced cellularity in the plaque. j) H&E stain of 
the area *, showing PIT and an intact media. Scale bars indicate 1 mm. Dynamic range of IVPA 
and IVUS image is 40 dB.  
We found that the lipid laden atherosclerotic plaque and diseased intima (Figures 6c 
and 6d, respectively) both had IVPA spectra that closely resemble the reference PA 
spectra of cholesterol oleate and cholesterol linoleate obtained on the pure compounds. 
This finding was in agreement with the assessment of the corresponding areas in the 
histological sections (Figures 6e,i and 6f,j, respectively), that showed lipid rich foam cells 
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and extracellular lipid droplets, but no cholesterol crystals. The H&E stain (Figures 6i,j) 
shows differences in cell density and orientation of cells in the intima (cell nuclei are 
colored blue/purple). The lower cell density of the more central plaque areas (Figure 8i) 
indicates a more advanced state of atherosclerosis with extracellular lipids (larger red 
spots in central region of ORO stain (Figure 8e). H&E (Figure 8j) also illustrates the 
much larger adipocytes in the peri-adventitial region 
The IVPA spectrum found in the adventitia, shown in Figure 8g, was very similar to 
both the absorption spectra of elastin and collagen, while the IVPA spectra of the lipid-
rich peri-adventitial tissue (Figure 8h) resembled the absorption spectrum of the 
reference fatty acid mixture38. 
Discussion 
Photoacoustic imaging adds highly detailed chemical information to existing 
diagnostic techniques for coronary atherosclerosis. We show its ability to outline fat 
deposits and to distinguish between plaque lipids and peri-adventitial lipids. The 
composition of lipid-rich plaques can be differentiated in cholesterol and a range of 
cholesterol esters by photoacoustic spectroscopy, opening up a new dimension for in 
vivo plaque characterization. Characteristic spectral signatures of collagen and elastin 
identify the adventitia; a contrast that may be of use in plaque imaging as well. No other 
clinically feasible imaging technique images the vessel wall and atherosclerotic plaque 
composition with such chemical specificity. 
IVPA is unique in its ability to distinguish the lipids present in atherosclerotic plaque 
at a high depth resolution of approximately 100 µm. Its visualization of different 
constituents of atherosclerotic plaques and deeper layers of the vessel wall is based on 
the intrinsic contrast in optical absorption between tissue types. The optical absorption 
spectrum is a much more specific tissue identification criterion than parameters like the 
attenuation and backscatter coefficients, that other techniques rely on for plaque 
composition. The background for this difference is that both optical scattering (which 
dominates optical attenuation) and acoustic absorption (which dominates acoustic 
attenuation) are slowly varying with frequency, so distinctive features like those seen in 
Figure 2 are not available for detailed composition imaging. NIRS, like IVPA, uses 
absorption spectra to determine lipid content, but does not have depth sensitivity.  
As a consequence, it can identify the presence but not the amount or the position of the 
lipid accumulation. NIRS has been combined with IVUS to add structural information but 
exact localization of the lipid core cannot be realized31. 
With the composition information provided by IVPA, tissue maps can be created, 
showing the location of different kinds of lipids (free cholesterol, cholesterol esters in 
foam cells or extracellular lipid droplets) as well as other tissue types (collagen, elastin) 
on top of the morphological picture provided by IVUS. Cholesterol oleate and cholesterol 
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linoleate together account for more than 67% of cholesterol esters present in lipid-rich 
lesions, while cholesterol esters and cholesterol together make up 79% of total lipids82. 
In the present study, we investigated the contribution of the three most significant 
components in the plaque lipid spectrum. Future studies need to establish the level of 
detail to which IVPA can unravel the lipid composition of plaques; this is both a 
fundamental question of the chemical specificity of the different absorption spectra as 
well as a technical question: how accurately can we measure the spectra to exploit that 
specificity, at a practical number of wavelengths? It is unknown at present how much 
composition detail is needed to establish whether a lesion is progressing towards 
rupture, quiescent or regressing towards stability. Beyond lipid composition, IVPA may 
be able to distinguish other tissue types or plaque characteristics that play a role in 
coronary artery disease, such as calcium, macrophages and intraplaque hemorrhage by 
choosing a different wavelength range or using exogenous contrast.  
Two issues that come into play when imaging ex vivo and need addressing, are lipid 
oxidation and temperature. Unsaturated lipids, such as cholesterol oleate and cholesterol 
linoleate, become oxidized when imaged ex vivo. But lipids in atherosclerotic lesions are 
partially oxidized as well: in freshly obtained carotid and femoral atherosclerotic plaque 
approximately 30% of plaque cholesterol linoleate was found to be oxidized, with 
CE18:2-OH and CE18:2=O (two oxidized forms of cholesterol linoleate) being the 
predominant forms83. However, since the number of C-H bonds does not change with 
oxidation, no change in the relative peak strengths in the absorption spectrum is 
expected; this supposition is strengthened by the results of the separate lipid PA 
measurements, where an increase in the level of oxidation of the lipids with time was 
anticipated, and the spectra remained structurally unchanged over time, as 
demonstrated in Figure 7. Similarly, a change in temperature from body temperature to 
room temperature is not expected to influence the position of peaks or relative peak 
height within the IVPA spectra, since these are dependent on the molecular structure, 
which does not change with temperature. NIRS was validated under the same 
assumptions32 and spectra were shown to be similar ex vivo and in vivo 84. 
For translation to in vivo imaging, several changes to the system need to be realized. 
The catheter needs to be further miniaturized and fitted with a compatible outer sheath. 
It needs to be coupled to a real-time imaging system through an interface unit containing 
a motorized fiber optical and pullback system, to make continuous rotation and 
simultaneous translation possible. Furthermore, the minimum number of wavelengths 
required to determine tissue type needs to be established, reducing acquisition time.  
A sufficient level of tissue composition information may be obtained by using three 
wavelengths only, if chosen wisely. Lasers to generate such wavelengths at fast enough 
pulse rates to achieve clinically feasible frame rates are currently under development.  
We demonstrated the ability of IVPA to distinguish lipid types as well as other kinds 
of tissues in coronary atherosclerosis. This functionality can aid in gaining further 
CHAPTER 5 
68 
understanding of the disease: it adds a new dimension to in vivo studies of progression 
and regression processes of plaque. This new functionality has a direct application in 
more complete visualization of coronary wall pathology for clinical decision making. 
Impacts in the medium to longer term include the introduction of highly detailed 
chemical imaging biomarkers as an endpoint in studies evaluating pharmacological 
therapies, and to measure the response of the arterial system to lifestyle changes in 
clinical trials. Imaging lipid composition in atherosclerotic plaque in vivo, and relating 
that information to its stage of advancement will contribute to further understanding of 
the development of the natural history of atherosclerosis. Finally, detailed imaging of 
plaque biochemistry and lipidomics may provide a jump-off point for personalized 
medicine in interventional cardiology, if we can predict the vascular response to an 
intervention of a specific site in a specific artery in a specific patient. 
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Abstract 
The presence of lipids in atherosclerotic coronary lesions is an important determinant 
of their potential to trigger acute coronary events. Spectroscopic intravascular 
photoacoustic imaging (sIVPA) has the potential to automatically detect lipids in 
atherosclerotic lesions. For real-time in vivo imaging, limiting the number of excitation 
wavelengths is crucial. We explored methods for plaque lipid detection using sIVPA, 
with the aim to minimize the number of laser pulses per image line. A combined 
intravascular ultrasound (IVUS) and photoacoustic imaging system was used to image a 
vessel phantom and human coronary arteries ex vivo. We acquired co-registered cross-
sectional images at several wavelengths near 1200 nm, a lipid-specific absorption band. 
Correlating the photoacoustic spectra at 6 or 3 wavelengths from 1185 to 1235 nm with 
the absorption spectrum of cholesterol and peri-adventitial tissue, we could detect and 
differentiate the lipids in the atherosclerotic plaque and peri-adventitial lipids, 
respectively. With two wavelengths, both plaque and peri-adventitial lipids were 
detected but could not be distinguished.  
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Introduction 
Coronary atherosclerosis is the largest cause of death in Western countries1. Most 
myocardial infarctions are triggered by the rupture of a so called vulnerable plaque2.  
The susceptibility of a plaque to rupture, its vulnerability, is determined by the 
morphology and composition of the plaque. The pathological phenotype associated with 
vulnerable plaques is the thin-cap fibroatheroma (TCFA), characterized by a 
macrophage infiltrated thin fibrous cap, covering a lipid rich necrotic core3-5. The necrotic 
core contains cholesterol crystals and extracellular droplets of cholesterol esters69. 
When the thin cap ruptures, due to high mechanical stresses, the lipid rich thrombogenic 
content of the TCFA can flow freely into the bloodstream and potentially causes an 
occlusion at the rupture location or downstream from that site. The presence and 
location of atherosclerotic lipids are therefore important markers of plaque vulnerability.  
No established technique can positively quantify and locate the lipid content of 
atherosclerotic plaques. Intravascular ultrasound (IVUS) produces cross-sectional 
images of the arterial wall based on the reflected amplitude of ultrasound pulses. Due to 
minimal contrast between soft tissue constituents, the sensitivity and specificity of IVUS 
grayscale for plaque composition is limited85. IVUS radiofrequency data analysis 
techniques for tissue characterization, namely VH-IVUS (20 MHz, phased-array 
transducer, Volcano Therapeutics), and iMap™ (40 MHz, mechanical-type transducer, 
Boston Scientific), have been developed as an extension to grayscale imaging22. 
However, the accuracy of VH-IVUS in complex lesions in a porcine model was 
limited24,25. Significant and systematic variability in plaque composition estimates was 
found in a study comparing VH-IVUS and iMap in vivo26. Intravascular optical coherence 
tomography (IVOCT) utilizes the delay in backscattered light to form an image of the 
illuminated tissue. Tissue characterization by IVOCT is currently under development30. 
OCT mainly relies on scattering contrast, which suggests that the chemical specificity is 
likely to be limited. Near infrared reflection spectroscopy (NIRS) is an intravascular 
catheter-based technique that utilizes optical absorption to detect lipid-core lesions. It 
lacks depth resolution, however, and cannot locate the position of the lipid-core relative 
to the lumen boundary86. By combining NIRS with IVUS, morphological imaging is added 
to lipid detection, but the amount and the location of the lipid relative to the lumen 
remains unknown31. 
Intravascular photoacoustics is an emerging technique that has the ability to image 
lipids in atherosclerotic lesions. It utilizes differences in the optical absorption spectra to 
identify tissue types. A specific tissue type in the arterial wall can be visualized by 
selecting an excitation wavelength that is strongly absorbed by that particular tissue.  
The chemical absorption spectrum then represents the molecular composition of  
the tissue. Well-known applications of spectroscopic PA imaging are detection of 
exogenous chromophores87 and quantification of blood oxygenation88. The capability of 
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spectroscopic IVPA (sIVPA) to image lipids in human coronary atherosclerotic arteries 
has been demonstrated ex vivo79. More recently, in vivo IVPA imaging of lipids inside the 
vessel wall of an abdominal rabbit aorta has been shown48. Spectral differences between 
lipid-rich and normal vascular tissue have been outlined by photoacoustic measurements 
of human aorta samples46 and pig carotid arteries89. In sIVPA, lipid content can be 
deduced from the photoacoustic spectra or comparison of co-registered IVPA images at 
different wavelengths.  
To be useful in the clinic, as a research tool or to guide percutaneous coronary 
interventions, however, atherosclerotic lipid content information needs to be readily 
available without the need for observer-dependent and time-consuming image 
interpretation. Ideally, only the lipids present within atherosclerotic plaques in the vessel 
wall are displayed, while the peri-adventitial lipids, which are a component of the normal 
vessel wall anatomy, remain hidden. That way, in an artery pullback, the cross-sections 
that contain plaque lipids will be obvious and can be distinguished easily, without clutter 
by false-positives from normal adipose tissue. For translation to in vivo imaging, where 
motion artifacts and thus imaging speed play an important role, the number of 
wavelengths needs to be as small as possible.  
In this study, we present a number of methods that provide sIVPA lipid detection in a 
semi-automated manner. We obtained sIVPA images of a lipid containing vessel 
phantom using a combined IVPA/IVUS imaging system and catheter. The collected 
sIVPA data were used to develop the different lipid detection methods. The methods 
were then fine-tuned and tested on sIVPA data of ex-vivo human coronary arteries, 
obtained using the same dual modality imaging system.  
 Methods 
Combined intravascular ultrasound and photoacoustic imaging system 
The dual modality imaging system for co-registered IVPA/IVUS imaging has been 
previously developed and described79. A tunable laser (OPOTEK Vibrant B/355-II) 
supplied the excitation light (pulse width 5 ns, repetition rate 10 Hz, pulse energy 1.2 mJ 
at catheter tip) for photoacoustic imaging. A tapered multimode fiber (Oxford 
Electronics, Four Marks, UK; input diameter 1 mm; output diameter 360 µm) collected 
the free space laser light output and delivered it to an in-house designed and built 
catheter. Two hybrid IVPA/IVUS catheter prototypes were used for this study.  
They both comprised a 400 µm diameter core optical fiber (Pioneer Optics, Bloomfield, 
CT) to deliver the light pulses to the vessel wall and an ultrasound transducer to transmit 
and receive ultrasound waves. The fiber tip was polished under a 34° angle covered by a 
quartz cap to maintain an air–glass interface deflecting the beam by total reflection. The 
first prototype, described in detail in earlier work79, contained a circular lead–zirconium–
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titanate (PZT) ultrasound transducer with a diameter of 1.0 mm (custom built by 
TUDelft; design by DuMED80). The transducer had a center frequency of 30 MHz,  
a -6 dB fractional bandwidth of 65% and was mounted distal from the fiber in an 
assembly with an outer diameter of 1.25 mm. The second prototype held a 0.4 by  
0.4 mm lead magnesium niobate-lead titanate (PMN-PT) single crystal ultrasound 
transducer (designed and custom built by the University of Southern California, 
Department of Biomedical Engineering58) with a center frequency of 44.5 MHz and a  
-6 dB fractional bandwidth of 45%. Fiber and transducer were mounted in an assembly 
with an outer diameter of 1 mm. In both prototypes, the fiber tip and transducer center 
were separated by approximately 1 mm and the optical and acoustical beam overlapped 
between 0.5 and 4.5 mm from the transducer, with an angle of 22°.  
An arbitrary waveform generator (Tabor Electronics WW2571A) transmitted  
a Gaussian-modulated cosine wave for pulse echo imaging, which was transmitted to the 
probe through a custom-built expander and limiter. The catheter was rotated using a 
motorized rotary stage (Steinmeyer GmbH & Co. KG). The received US and PA signals 
were band pass filtered (13–60 MHz 5th order Butterworth, custom built), amplified by a 
43 dB amplifier (Miteq AU1263) and digitized at a sample frequency of 350 MS s-1 by  
a 12-bit data acquisition card (Acqiris DP310).  
Phantom design 
We designed and constructed a vessel mimicking poly-vinyl-alcohol (PVA, 10% wt. 
PVA crystals in demineralized water, 2 freeze/thaw cycles) phantom with a 3 mm 
diameter lumen and four 1.5 mm round by 5 mm deep cylindrical cavities at 500 µm from 
the lumen. One cavity was filled with peri-adventitial tissue that we obtained from one of 
the human coronary artery specimens, see description below. In peri-adventitial tissue, 
lipids are stored as a mixture of fatty acids38. The other three cavities were filled with 
cholesterol, cholesterol oleate and cholesterol linoleate (Sigma Aldrich Co., C8667, 
C9253 and C0289, resp.). These three compounds are the most abundant lipids in 
atherosclerotic lesions90,91, and are assumed to be representative of plaque lipids.  
Reference absorption spectra of pure cholesterol, cholesterol linoleate, cholesterol 
oleate, and of peri-adventitial tissue, were acquired by recording the wavelength-
dependent PA signal. The respective lipids were held in a container made of TPX (TPX® 
Polymethylpentene) in a water bath in such a way that the there was a clear optical and 
acoustic path between the probe and the target. The data were averaged and processed 
to obtain spectra that were reproducible in time and depth, see Figure 1a. 
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Figure 1. a) Normalized reference PA spectra of cholesterol, cholesterol linoleate, cholesterol 
oleate, and peri-adventitial tissue, measured on the pure compounds. b) Correlation coefficients 
between the 6 and 3-wavelength PA spectra of the different lipid types. c) 5th to 95th percentile 
of the relative difference of 1205 nm and 1235 nm PA signal strength of cholesterol, cholesterol 
oleate, cholesterol linoleate and peri-adventitial lipids (672, 864, 512 and 372 spectra, 
respectively). The values for elastin and collagen are taken from literature38. c = cholesterol;  
cl = cholesterol linoleate; co = cholesterol oleate; pl = peri-adventitial lipids. 
Coronary artery acquisition and handling 
We collected human coronary arteries at autopsy from the Department of Pathology 
of the Erasmus Medical Center (MC). We obtained consent from the relatives and our 
research protocol was approved by the Medical Ethics Committee of the Erasmus MC 
(MEC-2007-081). The coronary arteries were measured freshly within 24h post mortem 
or frozen within 4h at -80° to be thawed and measured at a later date.  
Combined photoacoustic and ultrasound imaging 
We acquired combined photoacoustic and ultrasound images of the lipid containing 
vessel phantom and the human coronary arteries ex vivo. The vessel phantom was 
placed in a water bath, after which we inserted our combined IVPA/IVUS catheter in the 
lumen and recorded co-registered IVPA/IVUS cross-sectional data. The coronary 
arteries were placed in a holder and mounted on two cannulas in a water tank containing 
saline solution at room temperature. The holder was made of TPX with thin (200 µm) 
metal wires glued at every 1.5 mm perpendicular to the longitudinal axis to mark imaging 
locations. We then performed an IVUS pullback of the arteries using a commercial IVUS 
system (Boston Scientific iLab, Atlantis SR Pro catheters) to find sites of interest. Using 
our combined IVPA/IVUS catheter, the selected wires were found and at these locations 
co-registered IVPA and IVUS cross-sectional scans were made.  
To create the ultrasound images, we transmitted a 10 V peak to peak Gaussian-
modulated cosine wave with a center frequency of 30 MHz and a 100% bandwidth for 
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the first prototype catheter and a center frequency of 44.5 MHz and a 50% bandwidth 
for the second prototype catheter. Transmission bandwidths are specified at a -6dB level 
relative to the peak. With the exception of the phantom and first artery, the results of 
which are shown in Figure 2 and Figure 3, respectively, all arteries were measured using 
the second prototype catheter (44.5 MHz center frequency). 
We acquired IVPA images at several excitation wavelengths around 1200 nm. In this 
wavelength range, the second overtone of C-H bond vibrations within the different 
structural groups of the lipid molecules produce several overlapping peaks in the lipid 
absorption spectra. By staying within a relatively narrow wavelength range, we ensured 
that variations in the laser pulse energy and tissue scattering properties are negligible. 
Two-dimensional spatially co-registered spectroscopic IVPA and IVUS images were 
obtained by rotating the catheter in 1° steps and repeating the photoacoustic and 
ultrasound acquisitions at every step. IVUS images were obtained by averaging the 
echoes from 10 transmissions per line; IVPA was not averaged (one laser pulse per 
image line). At every angle, the laser was tuned through the spectral range of interest to 
ensure co-registration of the IVPA data at all wavelengths. Digitized IVPA and IVUS data 
were band pass filtered between 10 and 40 MHz and 10 and 70 MHz for the first and 
second catheter prototype, respectively (100th order zero-phase forward and reverse 
finite impulse response [FIR] filter). Filtered data were upsampled, corrected for jitter 
and downsampled to the original sampling frequency. Data that was affected by 
(environmental) noise benefited from additional median filtering in the angular direction, 
this concerned arteries 2 and 4 (kernel width 3° and 5°, respectively). 
IVPA data can be affected by an artifact caused by the absorption of laser pulses in 
the ultrasound transducer and catheter tip. It shows up in the images as bright rings, 
concealing the photoacoustic signals produced by the arterial tissue close to the probe. 
An adaptive filter was designed and applied to the IVPA data to remove this artifact. The 
IVUS data contained a similar circular artifact, caused by the ‘ringing’ of the transducer 
as a result of the transmission of ultrasound pulses, that we removed by subtracting the 
mean in the angular direction of the affected part of the data. Both the IVPA and IVUS 
data were then Tukey windowed and envelope filtered. The spectroscopic IVPA data was 
corrected for variations in the light energy between individual pulses and between the 
different wavelengths, using the amplitude in the ring artifact mentioned above. The data 
were subsequently scan-converted to Cartesian coordinates and log compressed. We 
used the ‘hot’ and ‘gray’ colormaps in Matlab (R2007b) to display the IVPA and IVUS 
images, respectively. Combined IVPA/IVUS images were created by overlaying the IVPA 
data on the IVUS images using a nonlinear red-yellow-white color scale and a linear 
transparency scale. All data processing was done using Matlab (R2007b).  
After imaging, the arteries were cut at the two wires adjacent to the imaging planes 
to obtain 3 mm thick artery segments with the imaged cross-section in the middle. The 
segments were embedded in optimal cutting temperature (OCT) compound (Tissue-
CHAPTER 6 
 
76 
Tek®, Sakura Finetek Europe B.V.), frozen in liquid nitrogen cooled isopentane vapor, and 
stored at -80 ˚C until serial sectioning for staining. Oil Red O (ORO) staining was 
performed to identify lipids (stained red). A Hematoxylin-Eosin (H&E) stain was used as 
an overview stain. To demonstrate the morphology and fibrous structure of the vessel 
cross-sections, a Resorcin-Fuchsin (RF) stain was used.  
Lipid detection methods 
Per imaging location, the spatially co-registered sIVPA data were used to obtain the 
lipid distribution within the vessel wall. We imaged a cross-section of the vessel 
phantom and the first artery at six equally spaced wavelengths between 1185 and  
1235 nm. Acquisition of a full image at six wavelengths is a time-consuming procedure, 
mainly because the laser takes time to tune. To limit tissue degradation, we performed  
6-wavelength imaging on one vessel only. The data were first processed as described 
above, up to scan-conversion. Then, for each pixel in the resulting data set, the 
correlation coefficient Rn=6 (n is the number of wavelengths) of the 6-wavelength PA 
spectrum with two different reference spectra was computed. We used the PA spectra 
of cholesterol and peri-adventitial tissue as reference spectra for plaque and peri-
adventitial lipids, respectively. The correlation coefficients between the various spectra 
(Figure 1b) show that the cholesterol spectrum has the lowest correlation with the peri-
adventitial spectrum and therefore is the most suitable to distinguish plaque from other 
lipids. 
The 6-wavelength correlation coefficients Rx,6 (x is lipid type; “c” for cholesterol or 
“pl” for peri-adventitial lipids) were median filtered over 4° in the angular direction and  
8 samples in the radial direction. The threshold values Rth,x,6 for the correlation 
coefficients were chosen empirically as the lowest values for which plaque lipids could 
be separated from peri-adventitial lipids. This exercise was performed in the phantom 
and in the artery specimens, discriminating lipid type based on location inside or outside 
the vessel wall. The lipid matching regions – those with a correlation coefficient equal to 
or higher than the threshold Rth,x,6 – were colored red and overlaid on the corresponding 
IVUS image to create a lipid map. 
We investigated the potential for identification and differentiation of the lipids using 
three and two wavelengths only. Several combinations of three wavelengths within the 
1185–1235 nm range were tested on the 6-wavelength data sets of the phantom and first 
artery. A three wavelength correlation will necessarily suffer more from accidental high 
correlation of the noise with the reference spectrum than a six wavelength correlation 
and therefore can be improved by applying a mask that cuts off the data at the noise 
level. We determined the noise level at 1205 nm by sampling the PA signal inside the 
lumen (identified in the IVUS image). All PA signal below that level was masked out. In 
these masked data, lipids were then detected in a manner similar to the 6-wavelength 
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data sets, and a new pair of correlation coefficients Rth,x,3, was chosen for both the 
phantom and artery measurement. 
Two-wavelength lipid detection was implemented using sIVPA data obtained at  
1205 and 1235 nm. At 1205 nm, lipid absorption is high, while at 1235 nm, the lipid 
absorption is reduced by 40 to 85%. Lipid maps were computed using the following 
algorithm: we determine the noise level at 1205 nm by sampling the PA signal inside the 
lumen (which can be identified in the IVUS image). All PA signal below that level is 
masked out. We compute the relative difference  = [I1205– I1235]/I1205, where I is the PA 
signal amplitude at wavelength .  is median filtered (4° angular by 8 samples radial). 
Lipids are identified by  > th = 0.37, where th is a threshold value determined from the 
analysis of the absorption spectra of pure lipids, see Figure 1c. We applied this method to 
the sIVPA data at 1205 and 1235 nm of the phantom and at several cross-sections of the 
human coronary arteries. 
Results 
Phantom 
We performed IVPA/IVUS on a lipid-containing vessel phantom at 6 evenly spaced 
wavelengths from 1185 to 1235 nm. The co-registered combined IVPA/IVUS images at 
1205 and 1235 nm are shown in Figures 2a and 2b, respectively. All four lipid containing 
cavities exhibit an increased PA signal at 1205 nm compared to the PA signal at 1235 nm. 
The lipid map resulting from the 6-wavelength correlation with the cholesterol reference 
spectrum, Figure 2d, detects the cholesterol and cholesterol esters, representative of 
plaque lipids, while the peri-adventitial tissue remains concealed. The correlation with 
the peri-adventitial reference spectrum, Figure 2e, results in detection of the peri-
adventitial tissue, while suppressing the other lipids. Figure 2f illustrates the resemblance 
of the average IVPA spectra in the lesion area indicated by the green sector in Figure 2d, 
and the peri-adventitial area (blue sector in Figure 2e), with their respective reference 
spectra. The atherosclerotic plaque and peri-adventitial lipid maps created using the  
3 wavelength correlation with the associated reference spectra, overlaid on the IVUS 
image, are shown in Figures 2g and 2h, respectively. The results shown here are obtained 
using 1185, 1205 and 1235 nm, which was the combination of wavelengths that resulted 
in the most specific separation between plaque and peri-adventitial lipids.  
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Figure 2. Lipid-detection in a lipid-containing vessel phantom. a) 1205 nm and b) 1235 nm 
combined IVPA/IVUS images (IVPA 50 dB, IVUS 65 dB) of PVA phantom filled with 
cholesterol (bottom), cholesterol oleate (right), cholesterol linoleate (top) and peri-adventitial 
tissue (left). c) Photograph of the phantom (top-view). Lipid map based on 6-wavelength 
correlation with the cholesterol d) and peri-adventitial reference spectrum e). f) Average IVPA 
signal spectra in the cholesterol and peri-adventitial tissue areas indicated in d and e, respectively, 
are highly correlated with their respective reference spectra. Lipid map based on 3-wavelength 
correlation with the cholesterol g) and peri-adventitial reference spectrum h). i) Lipid map based 
on 2-wavelength relative difference. All lipid maps are shown overlaid on the corresponding 
IVUS image. 
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The result of the 2-wavelength relative difference method using 1205 and 1235 nm is 
shown in Figure 2i. The method succeeds to display all the lipid regions well, but does 
not distinguish between atherosclerotic and peri-adventitial lipids. 
Table 1 lists the threshold correlation values Rth,x,6 and Rth,x,3 for 6 and 3 wavelengths 
respectively, which were used to create the lipid maps in Figures 2d–2e and 2g-2h.  
The 3-wavelength correlation method distinguishes equally well between the two lipid 
types as the 6-wavelength correlation. A slight decrease in the amount of lipids detected 
can be seen, however, which is caused by the addition of the noise masking step. 
Table 1. Threshold values Rth,x,n and th 
Method Threshold variable Phantom Artery 
6 λ 
Rth,c,6 0.88 0.93 
Rth,pl,6 0.85 0.85 
3 λ 
Rth,c,3 0.96 0.98 
Rth,pl,3 0.96 0.95 
2 λ th 0.37 
 
Arteries 
IVPA/IVUS was performed on a human coronary artery specimen exhibiting early 
stage atherosclerosis (left anterior descending artery, female aged 41, imaged < 24 h 
post mortem). Figures 3a and 3b show the co-registered combined IVPA/IVUS images 
at 1205 nm (high lipid absorption) and 1235 nm (low lipid absorption), respectively.  
In the IVUS image, the luminal border and the external elastic lamina are clearly visible. 
The images show two thickened intimal regions that exhibit a brighter signal in the  
1205 nm IVPA image than in the 1235 nm IVPA image. A brighter signal is also observed 
in the 1205 nm IVPA image in the peri-adventitial regions all around the vessel. The 
corresponding lipid stain, shown in Figure 3c, confirms the presence of lipids in the 
regions with enhanced 1205 nm IVPA signal. The three different lipid detection methods 
were applied to the co-registered IVPA data. The obtained optimal threshold values 
Rth,x,n, listed in Table 1, differ slightly from those found with the phantom data but show  
a similar trend. The findings are comparable to the lipid detection results in the phantom: 
Figure 3d clearly depicts the lipids in the fatty streak at the bottom right while 
suppressing successfully the peri-adventitial lipids. However, it fails to distinctly show 
the lipids present in the smaller fatty streak at the top of the vessel. In contrast, Figure 3e 
depicts the peri-adventitial lipids while suppressing the lipids present within the 
thickened intima. The plaque and peri-adventitial lipid maps created using the  
CHAPTER 6 
 
80 
3 wavelength (1185, 1205 and 1235 nm) correlation with the associated reference 
spectra, overlaid on the IVUS image, are shown in Figures 3g and 3h, respectively.  
 
Figure 3. Lipid detection in an early stage atherosclerotic human coronary artery. a) 1205 nm and 
b) 1235 nm combined IVPA/IVUS images (IVPA 35 dB, IVUS 40 dB). c) Lipid histology stain 
(ORO); lipids are stained red. Lipid map based on 6-wavelength correlation with the cholesterol 
d) and peri-adventitial reference spectrum e). f) Average IVPA signal strength in the lesion and 
peri-adventitial areas indicated in d and e, respectively, shows high correlation with the respective 
reference spectra. Lipid map based on 3-wavelength correlation with the cholesterol g) and peri-
adventitial reference spectrum h). i) Lipid map based on 2-wavelength relative difference.  
All lipid maps are shown overlaid on the corresponding IVUS image.  
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The 3-wavelength correlation with cholesterol seems to be working equally well as 
the 6-wavelength correlation, whereas the 3-wavelength peri-adventitial lipid correlation 
degrades slightly. The result of the 2-wavelength relative difference method using  
1205 and 1235 nm is shown in Figure 2i. As in the phantom case, the method succeeds to 
display all the lipid regions well, but does not distinguish between atherosclerotic and 
peri-adventitial lipids. Note that all lipid detection methods effectively suppress the 
strong PA signal from the wire that can be seen at the top of the IVPA images in  
Figure 2a and 2b.  
 
Subsequently, we acquired co-registered IVPA/IVUS images at 1205 and 1235 nm of 
several human coronary arteries exhibiting varying degrees of atherosclerosis. The lipid 
maps resulting from the 2-wavelength lipid detection method, overlaid on the IVUS 
images, are shown in Figure 4 through Figure 6 with collocated histology, always 
showing the ORO stain. Figure 4 demonstrates the lipid detection method on a healthy 
coronary artery (left anterior descending artery, male aged 65, imaged after frozen 
storage). Lipids are found in the peri-adventitial tissue only; this is confirmed by the lipid 
histology stain. The peri-adventitial fat is a very fragile structure, and as a result some  
of it has fallen off in tissue handling after imaging. 
 
Figure 4. Lipid detection in a healthy human coronary artery. a) Lipid map based on relative 
difference between PA signal at 1205 and 1235 nm, overlaid on IVUS image (40 dB). b) Lipid 
histology stain (ORO). c) 5 x magnification of a part of the healthy vessel wall and peri-
adventitial lipids (area outlined in black in b). Both in the lipid map and the lipid stain, lipids are 
found in the peri-adventitial region only. 
Two sites in an atherosclerotic human coronary specimen (left anterior descending 
artery, male aged 80, imaged after frozen storage) are shown in Figure 5. The IVUS 
image in Figure 5a shows a narrowed lumen with two plaques at the top right and the 
bottom of the vessel wall. The shadowing deeper in the plaque area at the bottom of the 
image indicates the presence of a calcification. 
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Figure 5. Lipid detection in a diseased coronary artery. a) Lipid map at first imaging location, 
based on relative difference between PA signal at 1205 and 1235 nm after masking the noise, 
overlaid on IVUS image (45 dB). b) Corresponding lipid histology stain (ORO). Lipids are found 
in the top and bottom plaque areas, as well as in the peri-adventitial region, in correspondence 
with the lipid stain. 10x magnifications of area c and d are shown in c) and d), respectively.  
e) Lipid map, created using the same 2-wavelength method, overlaid on 45 dB IVUS image, and 
f) lipid histology stain at second imaging location. The lipid map displays all locations with 
extracellular lipid droplets and cholesterol (areas g, h and i, shown 10x magnified in subfigures g, 
h and i, respectively) accurately. Peri-adventitial lipids that are located beyond the lesion are 
obscured. 
These findings are confirmed by the ORO lipid stain, which is depicted in Figure 5b. 
The lipid map, overlaid on the IVUS image, shows lipids in both the bottom and top 
plaque regions, accurately collocated with the atherosclerotic lipids visible in the lipid 
histology stain. The peri-adventitial lipids are only visible in the lipid map on the top left 
and bottom right, where the light and ultrasound waves penetrate deep enough to reach 
the tissue surrounding the vessel. At the next imaging location, excellent agreement 
between the lipid map overlaid on the IVUS image and the lipid histology stain is 
observed. The lipid stain reveals an eccentric plaque, with lipids located at specific 
locations in the lesion, see Figures 5e–5i. The lipid map assesses these lipid rich locations 
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accurately. The peri-adventitial lipids appear in all directions except behind the plaque, 
where the vessel wall is thickened considerably. 
Figure 6 shows the results of the combined IVPA/IVUS measurement of an eccentric 
plaque with diffuse intracellular lipid according to histology (left anterior descending 
artery, female aged 51, imaged fresh). The lipid-rich eccentric plaque, as imaged by 
IVPA, has a mottled appearance due to the lipids that are scattered throughout most of 
the lesion. The lipid map closely mimics the appearance of the plaque by showing small 
lipid specks distributed throughout the plaque region. Small lipid deposits in the vessel 
wall opposite the lesion and the larger lipid deposits of the peri-adventitial tissue show 
up as well. 
Discussion and conclusions 
This study demonstrates that spectroscopic intravascular photoacoustic imaging can 
automatically detect atherosclerotic and peri-adventitial lipids, as well as distinguish 
between them, with a small number of excitation wavelengths. We have developed and 
tested a number of, progressively simpler, methods using the co-registered sIVPA/IVUS 
data we acquired in a lipid containing vessel phantom and several human coronary 
arteries ex vivo. Correlation with a cholesterol PA spectrum, as reference for 
atherosclerotic lipids, and with a peri-adventitial reference spectrum, using 6 equally 
spaced wavelengths from 1185 to 1235 nm, distinguishes very well between 
atherosclerotic lipids and peri-adventitial lipids. Correlation using just 3 well-chosen 
wavelengths within this wavelength range, namely 1185, 1205 and 1235 nm, still achieves 
a satisfactory distinction between these two lipid types. Utilizing the relative difference 
between the PA signal at 1205 and 1235 nm, we successfully detected both the 
atherosclerotic and peri-adventitial lipids in several human coronary arteries. Separate 
depiction of the two lipid types was not achieved, even though PA data of the pure 
compounds (Figure 1c) suggest this as a possibility. In actual tissue, however, variability 
in optical properties and a lower signal-to-noise level preclude separation of lipid types. 
Evaluation of two-wavelength sIVPA in human coronary arteries ex vivo shows the 
appearance of different manifestations of disease, compared to histology: Figure 4 
shows a healthy artery, which by IVPA is characterized by an absence of lipid signal in 
the intima and media. Figures 5 and 6 compare large lipid deposits (Figures 5c and 5d) 
with small (Figures 5g–5i) and larger (Figure 6) extracellular lipid droplets. The lipid 
distribution by IVPA closely follows the histological appearance. 
Other methods have been reported for separating lipids from other tissue types49, 
relying on the acquisition of more wavelengths. This richer spectral sampling may 
increase robustness against measurement noise, permits automated spectral unmixing92, 
and possibly enhances chemical detail. A drawback is, however, that additional 
wavelengths lower the imaging speed proportionally, lengthening the acquisition time 
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and increasing the susceptibility to motion artifacts. For in vivo imaging, the number of 
wavelengths should be kept as small as possible. The difference in our approach 
compared to other techniques in the literature does complicate a direct performance 
comparison. 
 
Figure 6. Lipid detection in a coronary artery with an eccentric atherosclerotic lesion with lipids 
distributed throughout the plaque. a) Lipid map based on relative difference between PA signal at 
1205 and 1235 nm after masking the noise, overlaid on IVUS image (30 dB). b) Lipid histology 
stain (ORO). c) 10 x magnification of part of the plaque (area outlined in black in b).  
The distributed plaque lipids are displayed in the lipid map as small red marks throughout the 
lipid containing area. 
Catheter-based coronary imaging is usually performed by pulling back the catheter 
inside the artery under investigation, as it rotates. In this way, a large, volumetric data set 
is accumulated, which is reviewed during or after acquisition. A technology that 
automatically identifies lipid-rich plaques in the vessel greatly simplifies the review and 
interpretation process, and development of this functionality is one of the main drivers of 
this study. In principle, segmentation of the peri-adventitia based on the IVUS image is 
possible. In practice, however, automated IVUS image analysis has proven to be a very 
difficult problem, which is why we propose to exploit the chemical differences that exist 
between plaque lipids and others to generate image contrast. 
Incomplete depiction of the topmost fatty streak in the correlation lipid maps of the 
human coronary artery specimen imaged using six wavelengths (Figures 3d and 3g), was 
caused by filtering the data for artifact reduction, as discussed in section 2.4. The filter is 
nonlinear and this affects the spectral correlation that we compute. The 2-wavelength 
analysis (Figure 2i) appears to be more robust, retaining the feature partially. The 
catheter design will be adapted to considerably reduce this artifact in future 
experiments. In the peri-adventitial (Figures 3e and 3h), as well as the 2-wavelength lipid 
map (Figure 3i), of the same cross-section, a thin lipid-positive layer can be seen at the 
bottom left of the luminal border that is unmatched by histology. A piece of adipose 
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tissue may have been moved into the lumen in preparation for the experiment, and 
subsequently dislodged by tissue handling. 
This qualitative study demonstrates the viability of detecting arterial lipid with a 
limited number of wavelengths. It will be compounded in the future with a larger 
quantitative study to establish the optimal experimental and analysis procedures. Such a 
study should also include a statistical analysis to quantify the sensitivity and specificity 
of IVPA for lipid-rich plaque detection. Our findings seem to indicate a high sensitivity 
for extracellular lipid droplets, as illustrated in Figure 6, while intracellular lipids remain 
mostly undetected. The selection of wavelengths may be further optimized to improve 
sensitivity. Alternatively, sensitivity might be increased by imaging in the 1700 nm 
wavelength range, where lipid absorption is much higher48,49. Tradeoffs exist in the form 
of a high water absorption, which may present a challenge in this wavelength range, and 
the chemical specificity of the absorption spectra of the different lipids, which remains to 
be explored. Further automation of the analysis could be achieved by automatic contour 
detection in IVUS to determine the luminal noise level. The dynamic range in the images 
was adjusted to accommodate the dynamic range of the acquired data.  
In summary, we presented an analysis of sIVPA data to detect atherosclerotic lesion 
lipid content in a semi-automated fashion and with high resolution. The methods were 
demonstrated on human coronary arteries ex vivo and have the potential to be used in an 
in vivo setting. Automatic depth-resolved lipid detection of human coronary 
atherosclerosis may find an important role in the clinical detection and treatment, as well 
as the expansion of our understanding, of coronary artery disease. 
  
  
  
 
Chapter  7 
 
Photoacoustic imaging 
of human coronary 
atherosclerosis in two 
spectral bands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the manuscript by Krista Jansen, Min Wu, Antonius F. W. van der Steen, and 
Gijs van Soest, Comparison of spectroscopic photoacoustic imaging of human coronary 
atherosclerosis in two spectral bands. Photoacoustics, accepted for publication. 
CHAPTER 7 
88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Spectroscopic intravascular photoacoustic imaging (sIVPA) has shown promise to 
detect and distinguish lipids in atherosclerotic plaques. sIVPA generally utilizes one of 
the two high absorption bands in the lipid absorption spectrum at 1.2 µm and 1.7 µm. 
Specific absorption signatures of various lipid compounds within the bands in either 
wavelength range can potentially be used to differentiate between plaque lipids and peri-
adventitial lipids. With the aim to quantify any differences between the two bands, we 
performed combined sIVPA imaging in both absorption bands on a vessel phantom and 
an atherosclerotic human coronary artery ex vivo. Lipid detection in a human 
atherosclerotic lesion with sIVPA required lower pulse energy at 1.7 µm than at 1.2 µm 
(0.4 mJ versus 1.2 mJ). The imaging depth was 5 mm at 1.7 µm versus 10 mm at 1.2 µm. 
Adequate differentiation between plaque and peri-adventitial lipids was achieved at  
1.2 µm only.  
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Introduction 
Myocardial infarction is a leading cause of death worldwide1. In the majority of cases, 
they are caused by the rupture of an atherosclerotic plaque and the subsequent release 
of its thrombogenic content into the bloodstream2. The presence of a lipid rich necrotic 
core is one of the determinants of the susceptibility of a plaque to rupture3,4. For that 
reason, the identification of necrotic core is a highly coveted imaging target. 
Intravascular ultrasound (IVUS) radiofrequency data analysis techniques for tissue 
characterization (VH-IVUS, iMap) have been developed, but their accuracy and mutual 
consistency are still under investigation24-26. Near infrared spectroscopy (NIRS) in 
combination with IVUS, can identify the presence but not the amount or location, relative 
to the lumen, of the lipid core31-33.  
Intravascular photoacoustic (IVPA) imaging has demonstrated the ability to directly 
image tissue components in the vessel wall, with high chemical specificity for lipid type. 
It utilizes differences in the absorption spectra of the vessel wall constituents to identify 
tissue types. Efforts have primarily concentrated on lipid detection, and started in the 
visible wavelength range. With the introduction of suitable light sources, focus shifted to 
the near-infrared wavelength range, where hemoglobin absorption is much lower, 
allowing for better light penetration. In this wavelength range, the absorption spectra of 
lipids are characterized by two prominent features around 1.2 and 1.7 µm. These 
absorption bands are the result of the second and first overtones of the C–H bond 
vibrations within the lipid molecules, respectively. The 1.2 µm absorption band has been 
exploited extensively to distinguish lipids from healthy vessel wall, in rabbit43,44 as well as 
human45,46,79 atherosclerotic arteries. In recent years, lipid detection using excitation 
wavelengths around 1.7 µm has seen increased interest45,47-49. In this wavelength range, 
the higher lipid absorption possibly leads to increased sensitivity using lower light 
intensity. However, water absorption is higher too, which could potentially offset the 
increased sensitivity for lipids by limiting the penetration depth (Figure 1).  
Both absorption bands each consist of several overlapping peaks as a result of  
C–H bond vibrations within the different structural groups (–CH3, >CH2, ≡CH and >CH 
[aromatic]) of the lipid molecules66,81,93. The position and relative height of the peaks 
vary with the number and location of these different structural groups within the 
molecules and therefore provide chemical specificity. The possibility for differentiating 
between plaque lipids and peri-adventitial lipids, based on the specific absorption 
signature of the various lipid compounds, remains to be explored.  
These considerations outline tradeoffs in terms of sensitivity, imaging depth, and 
possibly chemical specificity connected to the choice of IVPA wavelength. In this paper, 
we present spectroscopic IVPA (sIVPA) imaging of a lipid containing vessel phantom 
and an atherosclerotic human coronary artery ex vivo at 1.2 µm and 1.7 µm, providing a 
direct comparison between the wavelength ranges. In the phantom, we acquired high-
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resolution spectra of cholesterol, cholesterol oleate and cholesterol linoleate, 
representative of plaque lipids, and peri-adventitial tissue. The resulting spectra were 
used to determine a limited number of wavelengths that maximize the difference 
between plaque and peri-adventitial lipids. At these wavelengths, we obtained co-
registered sIVPA/IVUS images of the vessel phantom that we used to detect the plaque 
and peri-adventitial lipids alternatively. With two wavelengths per spectral range only, 
the lipid detection capability in each range was examined using both the phantom data 
and the ex vivo data of a diseased human coronary artery specimen.  
 
Figure 1. a) Lipid and water absorption in the near-infrared wavelength region, showing the two 
high peaks in the lipid absorption spectrum around 1210 and 1720 nm. In these two optical 
windows, lipid absorption exceeds water absorption. Lipid absorption at 1720 nm is 5.5 times 
higher than at 1210 nm; water absorption is 5 times higher. Adapted from94. b) Transmission of 
light through water; computed based on data from http://omlc.ogi.edu/spectra/water/abs. 
Methods 
Phantom design 
To determine the capacity for lipid detection and differentiation at 1.2 and 1.7 µm, we 
made a cylindrical vessel mimicking phantom (Figure 1a). The phantom consisted of 10% 
(by weight) poly-vinyl-alcohol (PVA) crystals in demineralized water, that formed an 
acoustically transparent gel after 2 freeze/thaw cycles. It had a central lumen with  
a diameter of 3 mm and four 5 mm deep cylindrical cavities with a diameter of 1.5 mm, 
located at 500 µm from the lumen. We filled three cavities with cholesterol, cholesterol 
oleate and cholesterol linoleate (Sigma Aldrich Co., C8667, C9253 and C0289, resp.). 
These are the three most abundantly present lipids in atherosclerotic lesions90,91, and are 
assumed to be representative of plaque lipids. The fourth cavity was filled with peri-
adventitial tissue that was obtained from a human coronary artery specimen, see 
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description below. In peri-adventitial tissue, lipids are deposited as a mixture of fatty 
acids38.  
Human artery acquisition and handling 
A human coronary artery was collected at autopsy from the Department of Pathology 
of the Erasmus Medical Center (MC), after obtaining consent from the relatives and 
approval of the research protocol by the Medical Ethics Committee of the Erasmus MC 
(MEC-2007-081). The coronary artery was frozen within 4h at -80°C and stored. It was 
thawed and measured three months later.  
Combined intravascular photoacoustic and ultrasound imaging system 
All co-registered sIVPA/IVUS images were acquired using a combined IVPA/IVUS 
imaging system described previously79. The excitation light for photoacoustic imaging 
was supplied by a tunable laser (OPOTEK Vibrant B/355-II) with a pulse duration of 5 ns 
and a repetition rate of 10 Hz. The laser was coupled to the custom-built catheter by a 
tapered multimode fiber (Oxford Electronics, Four Marks, UK; input diameter 1 mm; 
output diameter 360 µm).  
The hybrid IVPA/IVUS catheter prototype we used is similar to those used earlier79, 
but with a different transducer. It comprised a 400 µm diameter core optical fiber 
(Pioneer Optics, Bloomfield, CT) to deliver the light pulses to the vessel wall. The fiber 
tip was polished under a 34° angle covered by a quartz cap to maintain an air–glass 
interface deflecting the beam by total reflection. An ultrasound transducer was placed 
distal from the fiber tip to transmit and receive ultrasound waves. The 0.4 by 0.4 mm 
lead magnesium niobate-lead titanate (PMN-PT) single crystal ultrasound transducer 
was designed and custom built by the Department of Biomedical Engineering of the 
University of Southern California58 and had a center frequency of 44.5 MHz and a -6 dB 
fractional bandwidth of 45%. The separation between fiber tip and transducer center 
was approximately 1 mm; the optical and acoustical beam overlapped between 0.5 and 
4.5 mm from the transducer, with an angle of 22°. The catheter tip assembly had an 
outer diameter of 1 mm. 
The catheter was rotated using a motorized rotary stage (Steinmeyer GmbH & Co. 
KG). For pulse echo imaging, an arbitrary waveform generator (Tabor Electronics 
WW2571A) transmitted a Gaussian-modulated cosine wave which was transmitted to 
the probe through a custom-built expander and limiter. Received US and PA signals were 
band pass filtered (13–60 MHz 5th order Butterworth, custom built), amplified by  
a 43 dB amplifier (Miteq AU1263) and digitized at a sample frequency of 350 MS s-1 by a 
12-bit data acquisition card (Acqiris DP310). 
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Phantom measurements 
Using the dual modality imaging system described above, we imaged the lipid 
containing vessel phantom in a water bath, with the combined IVPA/IVUS catheter 
positioned in the lumen. We first acquired a cross sectional IVUS image to locate the 
lipid inclusions. In the direction of each inclusion, we acquired sIVPA data from 1125 to 
1275 nm and from 1620 to 1780 nm in steps of 2 nm, to determine the PA spectra of 
each lipid compound. At every wavelength, 32 image lines were recorded. The average 
pulse energy at the catheter tip was 1.2 mJ in the 1.2 µm and 0.4 mJ in the 1.7 µm spectral 
range. By staying within a relatively narrow spectral window, the average laser pulse 
energy and tissue scattering properties could be assumed constant within each 
wavelength range. The resulting spectra were normalized to the peak value and analyzed 
to determine the wavelengths most suitable to distinguish plaque from other lipids: per 
wavelength range, 4 wavelengths for which the cholesterol spectrum differed most from 
the spectrum of peri-adventitial lipids were selected, after which 2 wavelengths were 
added to create a fairly distributed spacing. 
Next, we obtained two-dimensional spatially co-registered spectroscopic IVPA and 
IVUS images of the phantom at these 12 wavelengths (6 per wavelength range) by 
rotating the catheter in 1° steps and acquiring photoacoustic and ultrasound image lines 
at every step. At every angle, the laser was tuned through the spectral range of interest 
(1.2 and 1.7 µm) to ensure co-registration of the IVPA data at all wavelengths. For 
ultrasound pulse echo imaging, we transmitted a 10 V peak to peak Gaussian-modulated 
cosine wave with a center frequency of 44.5 MHz and a 50% -6 dB bandwidth relative to 
the peak. IVUS images were obtained by averaging the echoes from 8 transmissions per 
line; IVPA was not averaged (one laser pulse per wavelength per image line).  
Artery measurements 
 The human coronary artery was placed in a TPX (TPX® Polymethylpentene) holder 
with 200 µm thick metal wires glued at every 1.5 mm perpendicular to the longitudinal 
axis to provide image registration. The holder was then placed in a water tank containing 
a saline solution at room temperature. The artery was tied on a cannula through which 
the catheter was introduced. To find sites of interest, we performed an IVUS pullback 
using a commercial IVUS system (Boston Scientific iLab, Atlantis SR Pro catheters), 
using the metal wires as reference points. The selected wires were then found using our 
combined IVPA/IVUS catheter. 
Spatially co-registered sIVPA/IVUS cross sectional images were obtained by rotation 
of the catheter in 1° steps and acquiring photoacoustic and ultrasound image lines at 
every step. Two rotations were performed to obtain two co-registered images at  
1205 and 1235 nm, and at 1680 and 1710 nm, separately. At every angle, the laser was 
tuned from 1205 to 1235 nm in the first measurement, and from 1680 to 1710 nm in the 
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second measurement, to ensure co-registration of the IVPA data per wavelength range. 
The ultrasound signal transmitted for pulse echo imaging, as well as the number of 
averaging and the average pulse energy, were the same as in the phantom measurement. 
IVPA spectral data processing 
The digitized spectroscopic IVPA data of the four lipid inclusions in the phantom, 
were band pass filtered between 10 and 70 MHz using a 100th order zero-phase forward 
and reverse finite impulse response (FIR) filter, and subsequently upsampled, corrected 
for jitter and downsampled to the original sampling frequency. Next, a Tukey window 
and envelope filter were applied. A correction for variations in the light energy was 
employed, using the amplitude of the signal close to the transducer, which is caused by 
the absorption of laser pulses in the ultrasound transducer and catheter tip. Depth 
locations of high signal intensity were chosen by selection of all peaks above a certain 
threshold in the 1205 and 1710 nm enveloped signal traces, respectively. Spectra at 
selected locations were filtered using a fourth order digital smoothing polynomial 
(Savitzky-Golay) filter, 32 times averaged and normalized. 
sIVPA/IVUS image reconstruction 
The digitized IVPA and IVUS rotational data band pass filtered and jitter corrected 
like the spectroscopic scans described above. The 1.2 µm wavelength range IVPA data of 
the artery cross section where subsequently median filtered over 5 image lines in the 
angular direction for extra noise reduction. 
An adaptive filter was designed and applied to all rotational IVPA data to remove the 
artifact that was caused by the absorption of laser pulses in the ultrasound transducer 
and catheter tip. It presents in the IVPA image as bright rings, concealing the 
photoacoustic signals produced by the arterial tissue close to the catheter. A similar 
circular artifact in the IVUS data, caused by the ‘ringing’ of the transducer as a result of 
the transmission of ultrasound pulses, was removed by subtracting the mean in the 
angular direction of the affected part of the data. Both the IVPA and IVUS data were then 
Tukey windowed and envelope filtered. A correction for variations in the light energy 
between individual pulses and between the different wavelengths, using the amplitude in 
the ring artifact mentioned above, was applied to the IVPA data. We subsequently scan-
converted the IVPA and IVUS data to Cartesian coordinates and log compressed them 
for display. The ‘hot’ and ‘gray’ colormaps in Matlab (R2007b) were used for the IVPA 
and IVUS images, respectively. To create combined IVPA/IVUS images, we overlaid the 
IVPA data on the IVUS images using a nonlinear red-yellow-white color scale and  
a linear transparency scale. All data processing was done using Matlab (R2007b).  
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sIVPA data analysis for lipid differentiation and detection 
To investigate the capability of sIVPA in the two absorption bands to distinguish 
plaque from peri-adventitial lipids, the two 6-wavelength sIVPA data sets of the lipid 
containing vessel phantom were processed as described above, up to scan-conversion. 
For each pixel in the resulting data sets, the correlation coefficient R of the PA spectrum 
with two reference spectra was computed. We used the PA spectra of cholesterol and 
peri-adventitial tissue as reference spectra for plaque and peri-adventitial lipids, 
respectively. Of the plaque lipid spectra (Figure 2c and 2d), in either spectral range, the 
cholesterol spectrum has the lowest correlation with the peri-adventitial spectrum 
(Figure 2b) and therefore is the most suitable to distinguish plaque from other lipids. 
The 6-wavelength correlation coefficients Rx (x is lipid type; “c” for cholesterol or “pl” 
for peri-adventitial lipids) were median filtered over 4 degrees in the angular direction 
and 8 samples in the radial direction. The threshold values Rth,x for the correlation 
coefficients were chosen empirically: the lowest values for which plaque lipids could still 
be separated from peri-adventitial lipids were selected. To create a lipid map, the lipid 
matching regions – those with a correlation coefficient equal to or higher than the 
threshold value Rth,x – were displayed in red and overlaid on the corresponding IVUS 
image. 
We compared the potential of sIVPA at 1.2 µm and at 1.7 µm for lipid identification 
using two wavelengths, λh,ω and λl,ω (h  for high lipid absorption; l  for low lipid 
absorption) per wavelength range ω. We computed lipid maps of the phantom and 
artery cross section using the following algorithm: we determined the noise level at λh,ω 
by sampling the PA signal inside the lumen (identified in the IVUS image) and masked 
out all PA signal below that level. We then calculated the relative difference  
ω = [I (λh,ω) – I (λl,ω)] / I (λh,ω), where I (λ) is the PA signal amplitude at wavelength .  
 was subsequently median filtered over 4 degrees angular by 8 samples radial. Lipids 
were identified by  > th, where th are the threshold values determined from the 
analysis of the absorption spectra of pure lipids, see Figure 2c, Figure 2d and Figure 5.  
Histological validation 
After imaging, we cut the artery at the two wires adjacent to the imaging plane to 
obtain a 3 mm thick artery segment with the imaged cross-section in the middle.  
The segment was embedded in “optimal cutting temperature” (OCT) compound 
(Tissue-Tek®, Sakura Finetek Europe B.V.), frozen in liquid nitrogen cooled isopentane 
vapor, and stored at -80 ˚C until serial sectioning for staining. We performed Oil Red O 
(ORO) staining to identify lipids (stained red). A Hematoxylin-Eosin (H&E) stain was 
used to provide an overview of the artery cross section; a Resorcin-Fuchsin (RF) stain 
was used to demonstrate the morphology and fibrous structure of the vessel cross-
sections. 
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Results 
Lipid differentiation in phantom 
We performed sIVPA measurements in the directions indicated by the white dashed 
lines in the photograph (top view) of the phantom in Figure 2a. The data were analyzed 
as described in section 2.6 and the resulting averaged normalized PA spectra of 
cholesterol, cholesterol oleate, cholesterol linoleate and peri-adventitial tissue in  
the 1.2 and 1.7 µm wavelength range are shown in Figure 2c and 2d, respectively.  
 
Figure 2. Lipid containing vessel phantom and IVPA spectra of lipid inclusions. a) Photograph of 
the phantom (top-view), filled with cholesterol (bottom), cholesterol oleate (right), cholesterol 
linoleate (top) and peri-adventitial tissue (left). b) 6-wavelength correlation coefficients between 
the spectra of the lipid inclusions. c) Average, normalized PA spectra of the four lipid inclusions 
in the 1.2 μm wavelength range, and d) in the 1.7 μm wavelength range. c = cholesterol;  
cl = cholesterol linoleate; co = cholesterol oleate; pl = peri-adventitial lipids. 
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While the spectra at 1.2 µm exhibit mainly differences in relative peak height, the 
dominant differences at 1.7 µm are shifts in the locations of the peaks between  
the spectra of plaque and peri-adventitial lipids.  
We obtained cross sectional sIVPA/IVUS data of the lipid-containing vessel phantom 
at 6 wavelengths in both spectral ranges. The wavelengths are given in Table 1. The lipid 
maps resulting from the correlation of the data in the 1.2 µm range with the cholesterol 
and the peri-adventitial lipid reference spectrum are displayed in Figure 3a and 3b, 
respectively; The corresponding lipid maps obtained in the 1.7 µm range are shown in 
Figure 3c and 3d, respectively. 
Table 1. Wavelengths used for 6-wavelength lipid detection 
Wavelength range (µm) Wavelengths (nm) 
1.2 1185, 1195, 1205, 1215, 1225, 1235 
1.7 1680, 1710, 1718, 1726, 1734, 1751 
 
All lipid maps are overlaid on the associated, co-registered IVUS image. At 1.2 µm, 
the cholesterol and the two cholesterol esters, representative of plaque lipids, are all 
detected clearly, while the peri-adventitial tissue remained concealed (Figure 3a).  
At 1.7 µm, however, it was not possible to simultaneously detect the cholesterol oleate 
and keep the peri-adventitial tissue invisible. On the other hand, more of the cholesterol 
was detected than at 1.2 µm. The correlation with the peri-adventitial reference spectrum 
resulted in detection of the peri-adventitial tissue in the 1.2 µm wavelength range, while 
suppressing the other lipids (Figure 3b). In the 1.7 µm wavelength range, less of the peri-
adventitial tissue was detected (Figure 3d).  
Table 2 lists the threshold correlation values Rc,x for the 6-wavelengths at 1.2 and  
1.7 µm that were used to create the lipid maps in Figure 3a-3d. To be able to detect peri-
adventitial lipids while suppressing plaque lipids, the correlation coefficients had to be 
chosen much higher for the 1.7 than for the 1.2 µm wavelength range.  
Table 2. Threshold values Rth,x and th 
Threshold variable Wavelength range (µm) 
 1.2 1.7 
Rth,c 0.87 0.88 
Rth,pl 0.88 0.96 
th 0.37 0.23 
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Figure 3. Lipid typing in a lipid-containing vessel phantom using sIVPA at 1.2 and 1.7 μm.  
a) Lipid map based on 6-wavelength correlation with the cholesterol, and b) with the peri-
adventitial reference spectrum in the 1.2 μm wavelength range (1185, 1195, 1205, 1215, 1225 and 
1235 nm). c) Lipid map based on the 6-wavelength correlation with the cholesterol, and d) with 
the peri-adventitial reference spectrum in the 1.7 μm wavelength range (1680, 1710, 1718, 1726, 
1734 and 1751 nm). All lipid maps are shown overlaid on the corresponding IVUS image 
(dynamic range 65 dB). Plaque lipids, represented by cholesterol (bottom), cholesterol oleate 
(right) and cholesterol linoleate (top) are distinguished clearly from peri-adventitial tissue (left)  
at 1.2 μm, while lipid typing at 1.7 μm yielded an inferior result. 
Lipid detection in phantom and artery 
We investigated the ability of sIVPA to detect lipids using two wavelengths at 1.2 µm 
versus the 1.7 µm, in both the lipid containing vessel phantom and a human coronary 
artery ex vivo. The phantom results are shown in Figure 4. The co-registered combined 
IVPA/IVUS images at 1205 (high lipid absorption) and 1235 nm (low lipid absorption) 
and the resulting relative difference lipid map, are displayed in Figure 4a, 4b and 4c, 
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respectively. Figure 4d, 4e and 4f depict the corresponding high and low lipid absorption 
images in the 1.7 µm wavelength range, at 1710 and 1680 nm, and lipid map, respectively. 
In both wavelength ranges, all four lipid containing cavities exhibit an increased PA signal 
at λh compared to the PA signal at λl. In the 1.2 µm range IVPA images, however, a higher 
signal can be observed from non-lipid regions, compared to the 1.7 µm range IVPA 
images, due to the overall higher light fluence. Both lipid maps succeed equally well in 
displaying the peri-adventitial lipid region but the plaque lipids were displayed more 
clearly in the 1.7 µm wavelength range. The false positives in the 1.7 µm lipid map at  
2 times the distance of the lipids from the catheter are the result of incomplete 
suppression of the pulse echo signal that is generated by absorption of the light in the 
transducer and catheter tip. This ultrasound signal is also visible in the 1.2 µm range but 
is effectively suppressed, as well as the higher PA background signal. 
 
Figure 4. Lipid detection in a lipid-containing vessel phantom using sIVPA at 1.2 and 1.7 μm.  
a) 1205 nm and b) 1235 nm combined IVPA/IVUS images (IVPA 50 dB, IVUS 65 dB) of PVA 
phantom filled with cholesterol (bottom), cholesterol oleate (right), cholesterol linoleate (top)  
and peri-adventitial tissue (left). c) Lipid map based on 2-wavelength relative difference between 
the PA signal at 1205 nm and 1235 nm. d) Co-registered 1710 nm and e) 1680 nm combined 
IVPA/IVUS images (IVPA 50 dB, IVUS 65 dB) of the same cross section of the vessel phantom. 
f) Lipid map resulting from the 2-wavelength relative difference between the PA signal at  
1710 nm and 1680 nm. Both lipid maps are shown overlaid on the corresponding IVUS image. 
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The threshold values c to realize the lipid maps in Figure 4c and 4f, were chosen 
using the spectral data of the separate lipid compounds. The 5th to 95th percentile of the 
relative difference of the PA signal at high and low lipid absorption wavelengths of  
the individual (unaveraged) IVPA spectra measured in the lipid containing phantom 
were calculated (Figure 5). The relative difference of the absorption coefficient of elastin 
and collagen at these wavelengths, is shown as well. Threshold values were chosen as 
the midpoint between the lowest value found for the lipids and the highest value found 
for elastin and collagen (red dotted line). The resulting threshold values c in both 
wavelength are listed in Table 2.  
 
Figure 5. Relative difference of PA signal at high and low lipid absorption wavelengths of 
individual (unaveraged) IVPA spectra measured in the lipid containing phantom. a) 5th to 95th 
percentile of the relative difference of the 1205 nm and 1235 nm PA signal strength of 
cholesterol, cholesterol oleate, cholesterol linoleate and peri-adventitial lipids (32, 128, 160 and 
96 spectra, respectively). Data for elastin and collagen are obtained from38. b) 5th to 95th 
percentile of the relative difference of the 1205 nm and 1235 nm PA signal strength of same lipid 
components (same number of spectra). Elastin data obtained from95; collagen data from96.  
c = cholesterol; cl = cholesterol linoleate; co = cholesterol oleate; pl = peri-adventitial lipids. 
The results of the atherosclerotic human coronary specimen (left anterior descending 
artery, male aged 65) measurement are shown in Figure 6. The top row, Figures 6a-6c, 
displays the results obtained in the 1.2 µm wavelength range; the bottom row, Figures 
6d-6f, the results obtained using wavelengths around 1.7 µm. From left to right, the IVPA 
images at λh, the IVPA images at λl, and the 2-wavelength relative difference lipid maps 
are shown. All images are overlaid on the corresponding IVUS image. The IVUS images 
show a small lumen with an eccentric plaque at the bottom right of the vessel wall.  
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Figure 6. Lipid detection in an atherosclerotic human coronary artery using sIVPA at 1.2 and  
1.7 μm. a) 1205 nm and b) 1235 nm combined IVPA/IVUS images (IVPA 25 dB, IVUS 40 dB).  
c) Lipid map based on 2-wavelength relative difference between the PA signal at 1205 nm and 
1235 nm. d) 1710 nm and e) 1680 nm combined IVPA/IVUS images (IVPA 25 dB, IVUS  
40 dB). f) Lipid map resulting from the 2-wavelength relative difference between the PA signal at 
1710 nm and 1680 nm. Both lipid maps are shown overlaid on the corresponding IVUS image.  
g) Lipid histology stain (ORO); lipids are stained red; calcification is stained. h) 5x magnification 
of the part of the atherosclerotic plaque indicated as lipid rich by the lipid stains (area outlined in 
black in g), shows larger extracellular lipid droplets, while the lipids in all other parts of the lesion 
are intracellular or contained in small extracellular droplets. i) 4x magnification of area outlined in 
black in h). 
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A large calcification is present in the plaque, indicated by the shadowing in the plaque 
area. The ORO lipid stain, depicted in Figure 6g, confirms these findings (lipids in red; 
calcification black). The 1205 nm IVPA image shows a slightly enhanced signal from the 
lipid area in the top part of the plaque, as well as a strongly enhanced signal in the peri-
adventitial region around the vessel wall, compared to the 1235 nm IVPA image. In the 
1.7 µm range, the enhancement of the signal in the lipid rich plaque area is more 
pronounced than in the 1.2 µm range, while the signal enhancement in the peri-
adventitial region is comparable. Additionally, the calcified region produces much less 
signal around 1.7 µm, albeit still in the same order of magnitude as the signal produced by 
the plaque lipids. In accordance with the differences found by visual inspection of the 
IVPA images, both lipid maps indicate lipids in the top part of the lesion, as well as in the 
peri-adventitial tissue region around the vessel wall. In the 1.7 µm lipid map however, 
more intraplaque lipids are detected, due to the higher signal enhancement and therefore 
better signal to noise ratio. The signal from the calcification is suppressed successfully in 
both cases. The enlargements of the ORO lipid stain (Figures 6e and 6f) of the area 
indicated as lipid rich in the lipid maps reveal the presence of larger extracellular lipid 
droplets, whereas the lipids in all other parts of the lesion are intracellular or contained in 
small extracellular droplets. This preferential detection is possibly caused by a higher 
Grüneisen coefficient, a higher concentration of the lipids or a better matching of the 
generated PA signal frequency to the bandwidth of the transducer. The data presented 
here (in Figures 3, 4 and 6) show that the maximum lipid imaging depth at 1.2 μm is 
approximately twice as large compared to 1.7 μm. The exact numerical value depends on 
the optical (scattering and absorption) and acoustic (frequency-dependent attenuation) 
properties of the tissue. At 1.2 μm, lipid signal was received from tissue layers in the 
artery wall at a depth of 5 mm. 
Discussion and summary 
This study assesses the lipid detection and distinction capabilities of spectroscopic 
intravascular photoacoustic imaging in two absorption bands, around 1.2 µm and 1.7 µm. 
We acquired co-registered sIVPA/IVUS data of a lipid containing vessel phantom at  
6 wavelengths in either spectral window. Correlation with a cholesterol PA spectrum,  
as reference for atherosclerotic lipids, and with a peri-adventitial tissue reference 
spectrum, using 6 wavelengths from 1185 to 1235 nm, distinguishes very well between 
atherosclerotic lipids and peri-adventitial lipids. The same 6-wavelength correlation 
method applied on sIVPA data from 1680 to 1751 nm resulted in a poorer separation of in 
particular cholesterol oleate and peri-adventitial tissue. Applying a 2-wavelength relative 
difference method, we successfully detected all four lipid compounds present in the 
vessel phantom in both wavelength ranges, with a superior detection of all four lipids in 
the 1.7 µm region. In an ex vivo sIVPA/IVUS measurement of an human coronary artery, 
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we found superior plaque lipid contrast in the 1.7 µm wavelength range, with a lower 
pulse energy (0.4 mJ versus 1.2 mJ at 1.2 µm) and sufficient imaging depth (for this 
particular vessel cross section). Low pulse energy is an advantage because it lowers the 
optical power that needs to be dissipated in vivo, and also reduces artifacts in IVPA 
imaging caused by light absorption in the catheter. 
The relative difference between two wavelengths is a robust parameter to detect the 
lipids, also in the presence of strong water absorption in the longer wavelength band, as 
long as the signal received from the lipids is above the noise level. Note that a minimum 
of two wavelengths is required in both the 1.2 µm and the 1.7 µm wavelength range to 
distinguish lipids from other vessel wall constituents; the IVPA signal generated by 
calcium is in the order of magnitude of the signal from lipids around 1.7 µm and even 
higher around 1.2 µm. 
Minimization of the required number of wavelengths is important for clinical 
application: the acquisition speed is inversely proportional to the number of PA 
acquisition needed to compose an image line. Light sources are expected to represent a 
significant fraction of the cost of an IVPA system for clinical applicability, presenting 
another reason to limit the number of wavelengths. We demonstrated here that two 
wavelengths are sufficient, in principle, to detect lipids, but not to differentiate. Noise 
reduction in the acquisition and more sophisticated analysis, targeted to exploit spectral 
differences between the various lipid tissues, may yield more insight from a two-
wavelength combination.  
This study is qualitative in design, exploring several analysis methods applied to the 
different lipid absorption bands for lipid detection and differentiation by sIVPA. A larger 
quantitative study will be performed in the future to determine the most favorable 
wavelengths and the appropriate parameters used for processing. Such a study could 
also establish whether the imaging depth at 1.7 µm is sufficient to image the vessel wall 
of larger coronary arteries, such as the left main stem, completely. A larger ex vivo study 
will also elucidate the representativeness of pure cholesterol, cholesterol oleate, and 
cholesterol linoleate for the absorption spectra of real atherosclerosis. It will provide 
insight into the natural variability of the absorption spectrum, which the eventual choice 
of wavelength combinations will have to take into account. Photoacoustic imaging seems 
to favor the detection of larger extracellular lipid droplets. To quantify the sensitivity of 
sIVPA to the different forms and sizes of intraplaque lipids, a statistical analysis of a 
larger data set should be performed. 
In summary, we presented the lipid detection and typing capabilities of 1.2 µm and  
1.7 µm sIVPA. We observed superior lipid differentiation in the shorter wavelength range 
in a lipid containing vessel phantom. In the longer wavelength range, however, 
intraplaque lipid detection was improved, both in the vessel phantom as well as in an 
atherosclerotic human coronary artery, with lower pulse energy. 
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Intravascular photoacoustic (IVPA) imaging uses the intrinsic contrast in optical 
absorption between tissue types to visualize different constituents of atherosclerotic 
plaques. It is unique in its ability to image atherosclerotic plaque composition up to 
several millimeters depth and at a high depth resolution of approximately 100 µm.  
 
IVPA is an experimental technique that is undergoing rapid development to become  
a clinically viable technology. IVPA has been demonstrated to distinguish calcified 
plaque42, atheroma40,41, and more specifically lipids44,46,79 from healthy vessel wall, as well 
as the presence of macrophages through the use of exogenous contrast agents50. 
However, many facets of real-time clinical imaging still need to be resolved. We have 
taken several essential steps in the direction of in vivo IVPA imaging, in terms of catheter 
miniaturization, lipid visualization and differentiation, wavelength selection and 
automated lipid detection. An overview of these accomplishments is given below. At the 
same time, various important aspects of the light source, catheter design, safety aspects 
etc., are still under investigation. These specific challenges on the road to in vivo IVPA 
imaging are discussed at the end of this chapter.  
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Contributions of this study to the field of IVPA 
Practical in vivo implementation of IVPA requires the development of a dedicated 
catheter device. Catheter miniaturization is critical for intravascular application. 
Although many functioning combination catheters have been demonstrated previously, 
their large diameter has prevented intravascular use in human coronary arteries and they 
have only been tested on phantoms, rabbit aortas, and opened up human arteries.  
We have developed several combined optical/acoustic catheter devices that are capable 
of combined co-registered IVPA/IVUS imaging of human coronary arteries. With an 
outer diameter of 1.25 mm, we created the first fully integrated IVPA/IVUS catheter that 
was small enough to be inserted into human coronary arteries. We designed and built an 
experimental combined PA and US system to assess the imaging characteristics of the 
catheters using dedicated phantoms. The latest prototype has an outer diameter of 1 mm 
(Chapter 3). 
 
With these small experimental catheters it was possible to image human coronary 
arteries of deceased patients in a laboratory setting. For this purpose, we collected fresh 
human coronary arteries from autopsy, showing different stages of disease. The data 
collected from the artery measurements were used to investigate several aspects of 
sIVPA imaging to progress towards clinical application. We performed histopathology  
of all measured arteries to corroborate our findings. 
 
Using the prototype catheters, we demonstrated co-registered IVPA/IVUS imaging 
of human coronary atherosclerotic plaque. Spectroscopic IVPA (sIVPA) at different 
wavelengths around 1.2 µm, a lipid-specific absorption band, was performed to visualize 
the lipid content of an atherosclerotic lesion. IVPA spectra of a lipid rich area around a 
healthy vessel showed close resemblance to a reference lipid absorption spectrum, 
verifying the accuracy of IVPA imaging (Chapter 4).  
 
The natural history of atherosclerosis is marked by changes in the lipid biochemistry 
in the diseased arterial wall. As lesions become more vulnerable, different cholesterol 
species accumulate in the plaque. We explored the capability of sIVPA imaging to 
distinguish the most important lipid components of human atherosclerotic plaques: 
cholesterol and the two most prominent cholesterol esters, cholesterol oleate and 
cholesterol linoleate. Using reference PA spectra acquired on the pure compounds, we 
analyzed sIVPA data from human coronary plaques ex vivo, to image plaque composition 
in terms of cholesterol and cholesterol ester content. In addition, we visualized the 
deeper lying connective tissue layers of the outer vessel wall, as well as the fatty acid 
containing adipose cells in the peri-adventitial tissue (Chapter 5). 
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To be useful in the clinic, as a research tool or to guide percutaneous coronary 
interventions, however, atherosclerotic lipid content information needs to be readily 
available without the need for observer-dependent and time-consuming image 
interpretation. Ideally, only the lipids present within atherosclerotic plaques in the vessel 
wall are displayed, while the lipids in the tissue around the vessel, which are  
a component of the normal coronary anatomy, remain hidden. That way, in an artery 
pullback, which typically contains hundreds of cross-sectional images, the cross-sections 
that contain plaque lipids will be obvious and can be distinguished easily, without clutter 
by false-positives from normal adipose tissue. For translation to in vivo imaging, where 
motion artifacts and thus imaging speed play an important role, the number of 
wavelengths needs to be as small as possible. Therefore, we explored methods for 
plaque lipid detection and differentiation using sIVPA, with the aim to minimize the 
number of wavelengths. We imaged a vessel phantom and human coronary arteries ex 
vivo at several wavelengths near 1.2 µm. Using as few as three wavelengths, we could 
detect and differentiate the lipids in the atherosclerotic plaque and peri-adventitial lipids. 
With two wavelengths, both plaque and peri-adventitial lipids were detected but could 
not be distinguished (Chapter 6). 
 
sIVPA generally utilizes one of the two high absorption bands in the lipid absorption 
spectrum at 1.2 µm and 1.7 µm. Tradeoffs in terms of sensitivity, imaging depth, and 
possibly chemical specificity exist between the two spectral bands. We measured a lipid 
containing vessel phantom and an atherosclerotic human coronary artery ex vivo in both 
spectral bands to provide a direct comparison between the two wavelength ranges.  
We found a stronger lipid-specific signal in a human coronary atherosclerotic plaque at  
1.7 µm than at 1.2 µm, even though the pulse energy was lower. The penetration depth of 
the excitation light at 1.7 µm remained sufficient to image medium sized coronary 
arteries. On the other hand, discrimination between plaque lipids and lipid deposits in 
peri-adventitial tissue was more successful at 1.2 µm (Chapter 7). 
Towards clinical IVPA imaging of the vulnerable plaque 
Combination with other intravascular modalities 
IVPA is a tool for plaque composition imaging. It has limited ability to display plaque 
morphology, and should therefore be combined with another intravascular modality to 
maximize its potential for the detection of vulnerable plaques. Table 1 gives an overview 
of the advantages and disadvantages of the different intravascular imaging modalities 
and their capacity to detect the different markers of plaque vulnerability. There is no 
single technique that can determine plaque vulnerability completely, which is why multi-
modality imaging is frequently proposed. IVPA can differentiate between plaque 
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components by using the differences in the optical absorption spectra of different 
tissues, like NIRS. However, unlike NIRS, it has depth resolution which makes it possible 
to know the exact spatial location of the lipids relative to the lumen border. IVPA 
provides optical contrast with ultrasound imaging depth. If used in combination with 
IVUS, IVPA can provide information on plaque composition that complements the 
morphological information provided by IVUS. In the future, useful combinations with 
other imaging modalities are likely to be explored, such as an IVPA/OCT combination. 
Lipid sensitivity and specificity study 
We have performed a qualitative study that demonstrated the viability of detecting 
arterial lipid with a limited number of wavelengths. It will be compounded in the future 
with a larger quantitative study to establish the optimal experimental and analysis 
procedures. Such a study should also include a statistical analysis to quantify the 
sensitivity and specificity of IVPA for lipid-rich plaque detection. The selection of 
wavelengths may be further optimized to improve sensitivity. Using two wavelengths 
only, separate depiction of atherosclerotic plaque lipids and peri-adventitial lipids was 
not achieved, even though PA data of the pure compounds suggest this as a possibility. 
In actual tissue, however, variability in optical properties and a lower signal-to-noise 
level preclude separation of lipid types. Our findings seem to indicate high sensitivity for 
extracellular lipid droplets, while intracellular lipids remain mostly undetected. Possible 
causes for this observation are a higher concentration of the lipids, a higher Grüneisen 
coefficient, which quantifies the photoacoustic conversion efficiency, or the dimensions 
of the lipid droplets.  
IVPA of other markers of plaque vulnerability  
IVPA research has primarily focused on imaging of plaque lipids44,46,79. Other disease 
markers that have been successfully targeted are calcium and inflammatory markers, 
such as macrophages and matrix metalloproteinase (MMP) activity; the latter two 
through application of exogenous contrast agents97. Intraplaque hemorrhage is another 
marker of plaque vulnerability that is a potential candidate for IVPA imaging. In a 
prospective study, patients whose excised carotid plaque revealed plaque hemorrhage or 
marked intraplaque vessel formation demonstrated an increased risk of future vascular 
events, independent of clinical risk factors and medication use98. The free hemoglobin 
present in the hemorrhage region could provide optical contrast, primarily in the visible 
wavelength range99.  
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Table 1. Advantages and disadvantages of each intravascular modality 
 
Grayscale  
IVUS 
VH-IVUS/  
iMap 
Palpography NIRS IVOCT IVPA 
Image 
Cross-section 
structure 
Cross-section 
tissue type 
Radial strain 
map 
(elastogram) 
Lipid-core 
plaque map 
(chemogram) 
Cross-section 
structure 
Cross-
section 
tissue type 
Type of radiation Ultrasound Ultrasound Ultrasound Near-IR light Near-IR light 
(Near-IR) 
light + 
ultrasound 
Axial resolution 
(µm) 
100–200 > 250 450 N/A 10–15 100 
Lateral resolution 
(µm) 
300–500 300-500 300–500 1000 30-40 400–500 
Penetration (mm) 10 5 N/A unknown 1 5 
Contrast 
mechanism 
Acoustic 
scattering 
Acoustic 
spectrum 
tissue strain 
Optical 
absorption 
Optical 
scattering 
Optical 
absorption 
Pullback rate 0.5 mm/s 0.5 mm/s 0.5 mm/s 0.5 mm/s 20-40 mm/s N/A 
Flushing No No no no Yes TBD* 
Current status CS/CA CS/CA CS CS/CA CS/CA PCS 
Lumen area ++ ++ - - ++ ± 
Plaque burden ++ ++ - - - ± 
Positive 
remodeling 
++ ++ - - - ± 
Necrotic core ± ++ ++ ++ - ++ 
Fibrous-cap 
thickness 
- - - - + - 
TCFA** - ± ++ - + ± 
Plaque rupture + + - - ++ - 
Erosion - - - - + - 
Thrombus ± ± - - + - 
Inflammation - - - - ± ± 
Calcium ++ ++ ++ - + - 
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Table 1. Subscript 
Abbreviations: IVUS, intravascular ultrasound; VH, virtual histology; NIRS, near-infrared 
spectroscopy; IVOCT, intravascular optical coherence tomography; NIRF, near-infrared 
fluorescence; IVPA, intravascular photoacoustics. CA indicates clinically, commercially available; 
CS, clinical studies; PCS, pre-clinical studies; N/A, not applicable. 
* May not be required in specific wavelength bands (e.g., the near-infrared window) 
** The positive predictive value to detect “definite TCFA” (defined as agreement by both OCT 
and VH-IVUS) was 78% by OCT but only 46% by VH-IVUS by Sawada et al.100 
++, excellent; +, good; ±, possible; –, impossible. 
Data derived from Kubo and Akasaka101, Suh et al.102, MacNeill103 and Maehara104. Palpography 
data derived from Schaar et al.105 
Imaging through blood 
In order to obtain optimal photoacoustic signal strength, it is desirable to deliver as 
much light to the vessel wall as is possible within the physical boundaries of the 
instrument, and within the safety limits106. Blood is a strongly scattering tissue, which can 
markedly reduce the light intensity at the vessel wall, even at wavelengths in the near 
infrared region. Several ex vivo IVPA experiments have demonstrated IVPA imaging 
through blood45-48 but the image quality deteriorates considerably compared to a water-
filled lumen. Even when imaging at 1720 nm, at very high lipid absorption, the image 
quality and reliability of the atherosclerotic lipid detection by IVPA would be greatly 
improved by flushing. It therefore appears likely that IVPA imaging may involve flushing 
of the blood from the artery in the clinical setting. Blood clearing is standard practice in 
IVOCT imaging. Unlike IVOCT, IVPA does not rely on the complete suppression of 
scattering in the lumen, but only requires the delivery of sufficient power. This means 
that dilution, rather than complete clearing, may be good enough. The ultrasonic 
properties of the flush media used for OCT (iodixanol, a coronary angiography contrast 
agent, trade name VisipaqueTM (GE Healthcare) are not precisely known, so its suitability 
for IVPA needs to be investigated.  
Light sources  
IVPA poses a set of strict requirements on the light source. Lasers used in 
development of the technology are powerful and versatile, but slow at pulse repetition 
rates of 10-50 Hz. This low pulse frequency precludes practical in vivo imaging. 
Particularly if flushing is used, the optimal imaging sequence will be modeled on that of 
Fourier domain OCT: high frame rate, high pullback speed, short pullback time of <10 s. 
This acquisition protocol prescribes a light source with a repetition rate of the order of  
10 kHz, with wavelengths that generates relevant contrast. Such lasers are currently 
being developed. 
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Catheter miniaturization and real-time imaging system development  
The smallest combined IVPA/IVUS catheter diameter built to date has a diameter of 
1 mm. Current IVUS probes have an outer diameter of less than 1 mm, including the 
protective sheath in which they rotate. Future developments will reduce the IVPA 
catheter diameter to 1 mm or less for successful application in clinical practice.  
All-optical devices are much smaller but sacrifice IVUS functionality. An IVPA catheter 
operating on the principle we describe in this work may be further miniaturized through 
the use of a 100 µm core angle polished optical fiber with a smaller quartz cap,  
to produce a catheter tip with an outer diameter of 0.7 mm. The catheter tip will connect 
to a torque coil of the same outer diameter to create a flexible catheter that can be 
rotated from the proximal end. This ensures a total outer diameter of the catheter, 
including the protective sheath in which it rotates, of less than 1 mm. The catheter will 
attach to a driving unit, consisting of a translation and rotary motor, and an 
electrical/optical rotary joint. The current combined IVPA/IVUS imaging system is 
specifically designed to conduct explorative studies in a laboratory setting. Adjustments 
will have to be made to the system to make it suitable for real-time in vivo imaging.  
 
Once transformed into a real-time, clinically accepted imaging modality, IVPA has 
the potential for becoming the next intravascular imaging revolution. It will become a 
powerful tool for guidance of percutaneous coronary intervention, informing the decision 
of which plaque to treat and length to stent with detailed composition information. IVPA 
will also contribute to studies of plaque vulnerability, and allow quantification of the 
response to different forms of intervention (device, pharmacologic, lifestyle changes) 
with rich chemical detail in vivo72,107. It is well positioned to play a leading role in clinical 
studies as an imaging endpoint, to show changes in the lipid content of atherosclerotic 
plaques.  
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Summary  
Cardiovascular diseases (CVDs) remain the largest cause of death worldwide. Of the 
17 million deaths from CVDs in 2008, 7.3 million were caused by heart attacks. While in 
high-income countries deaths from CVDs have been declining over the past decades, 
low- and middle-income countries have seen a sharp increase. A large percentage of 
these deaths occurred before the age of 60. These premature deaths from CVDs reduce 
productivity and limit economic growth. Additionally, the health problems associated 
with CVDs pose a tremendous socio-economic burden on societies and can cause major 
suffering for those affected.  
Although CVDs are preventable to a large extent, risk factors like older age and 
family history cannot be taken away. Therefore, heart attacks can never be entirely 
eliminated and percutaneous coronary interventions will continue to save the lives of 
many experiencing a heart attack. During this procedure, the clogged coronary artery is 
reopened and a stent is placed to keep it from closing again. Unplanned repeat 
interventions are often needed, however, and in half of the cases the symptoms are 
caused by restenosis of the treated lesion. This fact illustrates the necessity for improved 
intervention procedures and thus a better understanding of the underlying disease itself, 
called atherosclerosis. 
The knowledge of the natural history of atherosclerosis and its causal relationship to 
cardiovascular events has increased enormously over the last decades. Was at one point 
calcification of the arteries believed to be the main wrongdoer, the current paradigm 
states that the rupture of a so-called vulnerable plaque lies at the origin of most heart 
attacks. The vulnerability of an atherosclerotic plaque – its susceptibility to rupture –  
is known to be related to the composition of the plaque, the distribution of mechanical 
stress within it, and the presence and extent of associated inflammation. One of the most 
common types of vulnerable plaques is the thin-cap fibroatheroma (TCFA). These 
lesions are characterized by a thin fibrous cap, weakened by the presence of 
macrophages (scavenger cells), covering a lipid-rich necrotic core. The necrotic core is 
the result of cell death inside a lesion by the accumulation of cholesterol species. It 
contains cell debris, cholesterol crystals and extracellular droplets of cholesterol esters. 
A concurring degradation of the supporting structure in the necrotic core enables its 
content to freely flow into the bloodstream upon rupture of the cap due to high stresses 
(high blood pressure). This necrotic core material is thrombogenic, which means that a 
blood clot will be formed upon contact with the blood and the artery can become 
clogged. When this happens in a coronary artery, the result will be a heart attack.  
The development, up to rupture, of vulnerable atherosclerotic plaques is still only 
partially understood and their identification is a central issue in cardiac imaging. 
Intravascular imaging techniques play a major role in the study of these lesions, but
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established techniques, such as intravascular ultrasound (IVUS) and optical coherence 
tomography (OCT), are unable to image plaque composition. They cannot positively 
identify and quantify lipid content, or distinguish between lipid types present in 
atherosclerotic plaques. To meet the need for plaque composition imaging in order to 
determine plaque vulnerability, we have developed a novel technique called intravascular 
photoacoustic imaging (IVPA). IVPA is a tool for plaque composition imaging that adds 
highly detailed chemical information to existing diagnostic techniques for coronary 
atherosclerosis.  
IVPA relies on the detection of acoustic waves generated by the absorption of short 
(nanosecond) light pulses. The dissipation of the absorbed optical energy causes 
instantaneous local thermal expansion of the tissue, which generates a broadband 
acoustic wave. The acoustic signal can be detected using an ultrasound transducer 
(microphone) such as employed in IVUS. The distance between an optical absorber and 
catheter can be inferred from the elapsed time between the optical excitation and the 
detection of the acoustic signal, analogous to counting the time between seeing a 
lightning flash and hearing its thunder. In this way, depth resolution is provided. IVPA is 
special in this regard; other chemical diagnostic methods such as Raman spectroscopy 
and near-infrared absorption spectroscopy lack this ability to resolve depth. In IVPA, a 
cross-sectional image is created by rotation of a IVPA catheter inside the vessel.  
At every angle, a light pulse is sent and the acoustic signal generated in the vessel wall is 
recorded. A coronary artery can be investigated by performing a ‘pullback’: while 
rotating, the catheter is pulled back through the artery. IVPA image contrast depends on 
differences in optical absorption at the excitation wavelengths. Greater optical 
absorption results in greater thermal expansion and hence a stronger acoustic signal. 
Plaque composition can be probed if the optical absorption for the different constituents 
differs. Every biological molecule has an absorption spectrum, acting as a chemical 
fingerprint. By selecting the excitation wavelength(s) for maximum absorption contrast 
between relevant vessel wall components, such as collagen, calcified tissue, and lipid 
material, IVPA can identify plaque composition.  
To date, lipids and calcification have been the primary targets of IVPA imaging, using 
endogenous contrast provided by the tissue absorption spectra. Considerable work has 
also been done on visualizing macrophages and matrix metalloproteinase activity, an 
indicator of plaque instability, using exogenous absorbers. However, many facets of real-
time clinical imaging still need to be resolved. We have taken several essential steps in 
the direction of in vivo IVPA imaging. 
Practical in vivo implementation of IVPA requires the development of a dedicated 
catheter device that is. Although many functioning combined IVPA/IVUS catheters have 
been demonstrated previously, their large diameter has prevented intravascular use in 
human coronary arteries. With an outer diameter of 1.25 mm, we created the first fully 
integrated IVPA/IVUS catheter that was small enough to be inserted into human 
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coronary arteries. An experimental combined PA and US system was built to assess the 
imaging characteristics of the catheters using dedicated phantoms (test models).  
The latest prototype has an outer diameter of 1 mm.  
With these small experimental catheters it was possible to image human coronary 
arteries of deceased patients in a laboratory setting. For this purpose, we collected fresh 
human coronary arteries from autopsy, showing different stages of disease. 
Histopathology was performed on all measured arteries to corroborate our findings. 
The data collected from the artery measurements were used to investigate several 
aspects of IVPA imaging to progress towards clinical application. Firstly, we 
demonstrated co-registered IVPA/IVUS imaging of lipids in human atherosclerotic 
coronary arteries. Spectroscopic IVPA (sIVPA) at different wavelengths around 1.2 µm,  
a lipid-specific absorption band, was performed to visualize the lipid content of an 
atherosclerotic lesion. 
As lesions become more vulnerable, different cholesterol species accumulate in the 
plaque. We showed that IVPA can be used to distinguish between the most important 
lipid components of human atherosclerotic plaques, which can be used to study the 
development of atherosclerotic lesions.  
To be useful in the clinic, as a research tool or to guide percutaneous coronary 
interventions, however, atherosclerotic lipid content information needs to be readily 
available without the need for observer-dependent and time-consuming image 
interpretation. We created methods to automatically detect and distinguish lipid types 
using as few as three wavelengths, making them applicable to an in vivo setting. These 
lipid detection methods successfully detected atherosclerotic lesion lipid content based 
on spectroscopic intravascular photoacoustic imaging data, in a semi-automated fashion 
and with high resolution.  
sIVPA generally utilizes one of the two high absorption bands in the lipid absorption 
spectrum at 1.2 µm and 1.7 µm. Tradeoffs in terms of sensitivity, imaging depth, and 
possibly chemical specificity exist between the two spectral bands. We provided a direct 
comparison of sIVPA of human coronary arteries in these two spectral bands and found 
a superior atherosclerotic lipid detection performance at 1.7 µm, discrimination between 
plaque lipids and lipid deposits in peri-adventitial tissue was more successful at 1.2 µm. 
The work presented in this thesis signifies several essential steps towards in vivo 
clinical IVPA imaging. Although many facets of real-time clinical imaging still need to be 
resolved, the contributions of this study to the field of IVPA, have moved the 
development of a real-time in vivo IVPA/IVUS system capable of imaging the lipid 
content of atherosclerotic plaques in clear view.  
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Samenvatting 
Cardiovasculaire aandoeningen vormen wereldwijd doodsoorzaak nummer één.  
Van de 17 miljoen sterfgevallen die ze in 2008 veroorzaakten, waren er 7.3 miljoen het 
gevolg van een hartinfarct. Veel mensen overlijden al voor hun 60ste levensjaar aan de 
gevolgen van cardiovasculaire aandoeningen. Deze vroegtijdige sterfte veroorzaakt een 
productiviteitsverlies en beperking van de economische groei. Bovendien vormen de 
bijbehorende gezondheidsproblemen een zware socio-economische belasting voor 
samenlevingen en de getroffenen zelf. 
Cardiovasculaire aandoeningen zijn voor een groot gedeelte te voorkomen door een 
gezonde levensstijl, maar risicofactoren als leeftijd en aanleg kunnen niet weggenomen 
worden. Hartinfarcten zullen dan ook nooit helemaal geëlimineerd kunnen worden en 
percutane coronaire interventies zullen de levens blijven redden van velen die een 
hartinfarct ondervinden. Tijdens deze dotterprocedure wordt de verstopte kransslagader 
geopend en wordt er een stent geplaatst om het vat open te houden. De symptomen 
komen helaas vaak terug en ongeplande herhaling van de behandeling is dan ook 
regelmatig nodig. In ongeveer de helft van de gevallen worden de symptomen 
veroorzaakt door een vernauwing op de behandelde locatie. Dit feit illustreert de 
noodzaak voor verbeterde interventieprocedures, waarvoor een beter begrip van de 
onderliggende aandoening, atherosclerose, nodig is. 
Atherosclerose is een ontstekingsproces dat gekarakteriseerd wordt door de 
ophoping van vet, macrofagen, bindweefsel, gladde spiercellen en calcium in de 
vaatwand. Zo’n ophoping wordt een atherosclerotische plaque genoemd. De kennis over 
de ontwikkeling van atherosclerose en het oorzakelijk verband met het ontstaan van 
hartinfarcten is enorm toegenomen gedurende de laatste decennia. Werd op een 
bepaald moment nog gedacht dat calcificatie van de kransslagaders de belangrijkste 
boosdoener was, inmiddels weten we dat het scheuren van een kwetsbare plaque de 
oorzaak is van veruit het grootste deel van alle hartinfarcten. De kwetsbaarheid van een 
plaque wordt bepaald door de samenstelling, de verdeling van de mechanische belasting 
en de mate van ontsteking in de plaque. Het merendeel van deze kwetsbare plaques 
bestaat uit een vetrijke necrotische kern, bedekt met een dunne fibreuze kap, die 
verzwakt is door de aanwezigheid van macrofagen (afweercellen die dood celmateriaal 
en vet opruimen). De necrotische kern bestaat uit dood celmateriaal, cholesterol 
kristallen en druppels vloeibare cholesterolesters. Tijdens het ontstaan van deze 
necrotische kern vindt er een afbraak van de ondersteunende structuur plaats, waardoor 
bij scheuring van de kap als gevolg van hoge belasting (hoge bloeddruk) de inhoud vrij de 
bloedstroom in kan vloeien. Op het moment dat de inhoud van de plaque in contact komt 
met het bloed ontstaat er een bloedstolsel dat het vat kan afsluiten. Als dit in een 
kransslagader gebeurt, is een hartinfarct het gevolg.  
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De ontwikkeling van kwetsbare plaques tot aan het moment van scheuren, wordt nog 
maar gedeeltelijk begrepen en de identificatie van kwetsbare plaques is een centraal 
thema binnen de cardiologische beeldvorming. Intravasculaire technieken spelen een 
belangrijke rol bij het onderzoek naar deze plaques maar bestaande diagnostische 
technieken, zoals intravasculair ultrageluid (IVUS) en optische coherentie tomografie 
(OCT), kunnen de samenstelling van plaques niet in beeld brengen. Wij hebben een 
nieuwe techniek ontwikkeld, intravasculaire fotoakoestiek (IVPA), die plaque 
samenstelling in beeld kan brengen door gebruik te maken van het optische contrast 
tussen weefsels.  
IVPA berust op de detectie van akoestische signalen die gegenereerd worden door de 
absorptie van korte (nanoseconde) lichtpulsen. De geabsorbeerde optische energie 
wordt omgezet tot warmte en veroorzaakt een kortstondige thermische uitzetting van 
het weefsel, wat vervolgens een akoestisch signaal genereert. Het akoestisch signaal kan 
gedetecteerd worden met een ultrageluid transducer (zender-ontvanger) zoals ook in 
IVUS gebruikt wordt. De afstand tussen het optisch absorberend weefsel en de 
transducer kan afgeleid worden uit de tijd tussen het plaatsvinden van de lichtpuls en het 
ontvangen van het akoestische signaal. Dit is vergelijkbaar met het bepalen van de 
afstand van een bliksemflits door middel van het tellen van de tijd tot je de donder hoort. 
Op deze manier wordt diepteresolutie gecreëerd, zodat 3D plaatjes van de vaatwand 
gemaakt kunnen worden. IVPA is bijzonder in dit opzicht: andere diagnostische 
methodes die de plaque samenstelling kunnen meten, zoals Raman spectroscopie en 
nabij-infrarood absorptie spectroscopie, hebben geen diepteresolutie. In IVPA wordt een 
dwarsdoorsnede-afbeelding van een vat gemaakt door middel van de rotatie van een 
IVPA katheter binnen in het vat. In iedere richting wordt een lichtpuls verzonden en het 
gegenereerde akoestisch signaal opgenomen. Een kransslagader kan in zijn geheel in 
beeld gebracht worden door de katheter al roterend door het vat te verplaatsen.  
Het contrast in IVPA beelden hangt af van de verschillen in de absorptie van het licht bij 
de golflengte die gebruikt wordt. Meer optische absorptie zorgt voor grotere thermische 
expansie en dus een sterker akoestisch signaal. Plaque samenstelling kan bepaald 
worden wanneer de optische absorptie van de aanwezige bestanddelen van elkaar 
verschilt. Elk biologisch molecuul heeft zijn eigen absorptiespectrum dat als chemische 
vingerafdruk dient. Door lichtgolflengtes te kiezen die maximaal absorptiecontrast 
tussen de verschillende weefseltypen geven, kan met IVPA de plaque samenstelling in 
beeld gebracht worden. 
De nadruk bij IVPA onderzoek heeft tot nu vooral gelegen op het visualiseren van 
vetten en calcium in atherosclerotische plaques. Ook macrofagen en andere 
ontstekingsfactoren zijn met IVPA in beeld gebracht. Veel aspecten van de klinische real-
time implementatie IVPA zijn echter nog onbekend. Het doel van dit onderzoeksproject 
was het nemen van verscheidene essentiële stappen op de weg naar de klinische 
toepassing van IVPA. 
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Voor de praktische uitvoering van IVPA is de ontwikkeling van een speciaal katheter 
noodzakelijk. Hoewel al verscheidene goed functionerende combinatie IVPA/IVUS 
katheters geproduceerd zijn, verhinderde hun grote omvang intravasculair gebruik in 
menselijke kransslagaders. Wij hebben de eerste IVPA/IVUS katheter vervaardigd die, 
met een buitendiameter van 1.25 mm, klein genoeg is om in menselijke kransslagaders in 
te brengen. Verdere miniaturisatie heeft een prototype katheter opgeleverd met 
buitendiameter van slechts 1 mm. Met deze katheters, in combinatie met een 
zelfgebouwd experimenteel beeldvormingssysteem, hebben we intravasculaire metingen 
verricht in menselijke kransslagaders van overleden patiënten. We hebben 
histopathologie van de gemeten vaten gebruikt als controlemeting.  
Met de data van deze experimenten hebben we verschillende aspecten van de 
klinische applicatie van IVPA onderzocht. Allereerst hebben we het vet in een 
atherosclerotische plaque in beeld gebracht, door gebruik van licht van verschillende 
golflengten rond 1.2 µm, waar zich een grote piek in het absorptiespectrum van vetten 
bevindt. 
Naarmate plaques kwetsbaarder worden, verandert ook de samenstelling van de 
aanwezige vetten. Wij hebben aangetoond dat met IVPA de belangrijkste 
vetcomponenten van menselijke plaques in beeld gebracht kunnen worden.  
Deze mogelijkheid kan gebruikt worden om de ontwikkeling van atherosclerotische 
plaques te bestuderen.  
Voor de klinische toepassing van IVPA als onderzoeksinstrument of als hulpmiddel 
bij dotterprocedures, moet de informatie over de vetinhoud van plaques direct 
beschikbaar zijn, zonder dat waarnemer-afhankelijke en tijdrovende beeldinterpretaties 
nodig zijn. Wij hebben methodes ontwikkeld waarmee de vetten automatisch 
opgespoord kunnen worden en waarmee bovendien vetten in plaques van andere in de 
vaatwand aanwezige vetten onderscheiden kunnen worden. 
IVPA gebruikt doorgaans licht met een golflengte van rond de 1.2 µm of 1.7 µm. 
Tussen deze twee golflengtegebieden zien we verschillen in gevoeligheid voor vetten, de 
diepte waarop we de vetten nog kunnen zien en de mogelijkheid om verschillende vetten 
van elkaar te onderscheiden. We hebben een directe vergelijking gemaakt door het 
meten van menselijke kransslagaders in beide golflengtegebieden en vonden een 
superieure vetdetectie met IPVA rond 1.7 µm, terwijl plaque vetten beter van andere 
vetten te onderscheiden waren met IVPA rond 1.2 µm. 
Het werk dat in dit proefschrift gepresenteerd wordt, vertegenwoordigt verscheidene 
essentiële stappen in de richting van de klinische toepassing van IVPA. Hoewel veel 
facetten van klinisch gebruik nog uitgewerkt moeten worden, heeft dit werk de 
ontwikkeling van een real-time klinisch IVPA/IVUS systeem waarmee atherosclerotische 
vetten automatisch gedetecteerd kunnen worden aanzienlijk dichterbij gebracht. 
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